TW202011993A - Hydrated adhesive skin patch - Google Patents

Hydrated adhesive skin patch Download PDF

Info

Publication number
TW202011993A
TW202011993A TW108122813A TW108122813A TW202011993A TW 202011993 A TW202011993 A TW 202011993A TW 108122813 A TW108122813 A TW 108122813A TW 108122813 A TW108122813 A TW 108122813A TW 202011993 A TW202011993 A TW 202011993A
Authority
TW
Taiwan
Prior art keywords
mass
monomer
adhesive
water
acrylate
Prior art date
Application number
TW108122813A
Other languages
Chinese (zh)
Inventor
丹羽勝久
金箱眞
Original Assignee
日商日絆股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日絆股份有限公司 filed Critical 日商日絆股份有限公司
Publication of TW202011993A publication Critical patent/TW202011993A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

There is provided a hydrated adhesive skin patch that keeps viscosity even after moisture in an adhesive layer evaporates. A hydrated adhesive skin patch to be combined with an acrylic acid alkyl ester copolymer in an adhesive layer, the acrylic acid alkyl ester copolymer being the copolymer of a monomer mixture comprising monomer A and monomer B. The monomer A is a polymer where a glassy-transition temperature (Tg) is 270K or more when the monomer A is homopolymerized while the monomer B is a polymer where a glassy-transition temperature (Tg) is 220K or less when the monomer B is homopolymerized. The ratio of the monomer A is 30 mass% or more and 50 mass% or less relative to the whole mass of the monomer mixture.

Description

含水系貼附劑Aqueous patch

本發明係關於一種含水系貼附劑,詳細而言,係關於一種即便於黏著劑層中之水分揮散後亦維持較高之黏著力,且皮膚刺激性較低之含水系貼附劑。The present invention relates to an aqueous patch. In detail, it relates to an aqueous patch that maintains a high adhesive force even after the water in the adhesive layer is scattered and has low skin irritation.

一般亦稱為「敷劑」之使用含水之黏著基劑之貼附劑(本說明書中稱為含水系貼附劑)係於不織布等支持體上具備含有藥物等有效成分之膏體層(黏著劑層)之貼附劑之一種。敷劑由於膏體層使用有含水之黏著基劑,故有雖皮膚刺激性較低但黏著力較弱,尤其是黏著力會伴隨膏體層中之水分之揮散而經時性地降低,較容易自皮膚剝離之問題。 為了解決此種問題,已知有如下技術,其係將分散有作為構成非水系(亦稱為疏水性、親油性)黏著劑之一成分為人所知之丙烯酸烷基酯共聚物的乳液(亦稱為乳液)基劑調配至含水系貼附劑之膏體層(黏著劑層)。Adhesives that use water-based adhesive bases (referred to as aqueous-based adhesives in this specification), also known as "dressings", are provided on a support such as a nonwoven fabric with a paste layer (adhesive) containing active ingredients such as drugs Layer) is a kind of adhesive. The adhesive layer contains a water-based adhesive base, so although the skin irritation is low, the adhesion is weak, especially the adhesion will be reduced with the sway of the water in the paste layer over time, it is easier to self The problem of skin peeling. In order to solve this problem, there is known a technique in which an emulsion of an alkyl acrylate copolymer known as one of the components constituting a non-aqueous (also called hydrophobic and lipophilic) adhesive is dispersed ( (Also called emulsion) The base is formulated into the paste layer (adhesive layer) of the water-based adhesive.

例如,專利文獻1中揭示有一種貼附劑(比較品),其係將1%之丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂乳液(商品名 NiKasol TS-620,日本電石工業(股))調配至敷劑基劑(膏體)而成。 專利文獻2中揭示有一種含水系外用貼附劑,其以提供一種能夠表現出長時間貼附時之黏著力及再黏著力、抑制伴隨水分喪失之硬化及柔軟度之降低、及抑制剝離時之支持體之斷裂的含水系貼附劑為目的,而以相對於含水系外用貼附劑用組合物整體為0.01質量%以上10.0質量%以下之比率含有水分散性界面活性劑,且以相對於含水系外用貼附劑用組合物整體為5.0質量%以上10質量%以下之比率含有丙烯酸甲酯-丙烯酸2-乙基己酯共聚物。 專利文獻3中揭示有一種敷劑,其以提供一種即便於因時間經過而敷劑之含水量減少時亦具有充分之附著力之敷材為課題,含有聚丙烯酸中和物、該中和物之2.5~10倍質量(以膏體為基準5~25質量%)之丙烯酸甲酯-丙烯酸2-乙基己酯共聚物、及聚丙烯酸。 專利文獻4中揭示有一種敷劑,其以提供一種能夠以更小之力將剝離襯墊剝離之敷材為目的,含有聚(丙烯酸甲酯/丙烯酸2-乙基己酯)、及聚乙二醇脂肪酸酯等界面活性劑。 專利文獻5中揭示有一種使用含有丙烯酸樹脂乳液(商品名 NiKasol TS-620)1.5重量%、聚丙烯酸鈉6.2重量%之黏著劑組合物而獲得冷熱片材之觀點。 [先前技術文獻] [專利文獻]For example, Patent Document 1 discloses a patch (comparative product), which is a 1% methyl acrylate-2-ethylhexyl acrylate copolymer resin emulsion (trade name NiKasol TS-620, Japan calcium carbide industry (share )) It is formulated into the base of the dressing (paste). Patent Document 2 discloses an aqueous external-use adhesive, which provides an adhesive and re-adhesive force capable of exhibiting long-term adhesion, suppressing hardening and loss of flexibility accompanying loss of moisture, and suppressing peeling The water-based adhesive agent of the fracture of the support is for the purpose of containing the water-dispersible surfactant at a ratio of 0.01% by mass or more and 10.0% by mass or less with respect to the entire composition of the aqueous system-use external adhesive agent. The composition for an aqueous external-use patch composition contains a methyl acrylate-2-ethylhexyl acrylate copolymer in a ratio of 5.0% by mass or more and 10% by mass or less. Patent Document 3 discloses a dressing that aims to provide a dressing that has sufficient adhesion even when the water content of the dressing decreases with time, and contains a polyacrylic acid neutralizer and the neutralizer 2.5 to 10 times the mass (5 to 25% by mass based on the paste) of methyl acrylate-2-ethylhexyl acrylate copolymer and polyacrylic acid. Patent Document 4 discloses a dressing which contains poly(methyl acrylate/2-ethylhexyl acrylate) and polyethylene for the purpose of providing a dressing capable of peeling off the release liner with less force. Surfactants such as glycol fatty acid esters. Patent Document 5 discloses the idea of obtaining a hot and cold sheet using an adhesive composition containing 1.5% by weight of acrylic resin emulsion (trade name NiKasol TS-620) and 6.2% by weight of sodium polyacrylate. [Prior Technical Literature] [Patent Literature]

[專利文獻1]日本專利特開平9-208462號公報 [專利文獻2]日本專利第5650684號說明書 [專利文獻3]日本專利第5921779號說明書 [專利文獻4]國際公開第2016/104227號 [專利文獻5]日本專利特開2002-104957號公報[Patent Document 1] Japanese Patent Laid-Open No. 9-208462 [Patent Document 2] Specification of Japanese Patent No. 5650684 [Patent Document 3] Specification of Japanese Patent No. 5921779 [Patent Document 4] International Publication No. 2016/104227 [Patent Document 5] Japanese Patent Laid-Open No. 2002-104957

[發明所欲解決之問題][Problems to be solved by the invention]

如上所述,已知有為了提高含水系貼附劑之黏著持續性,將丙烯酸甲酯-丙烯酸2-乙基己酯共聚物等丙烯酸烷基酯共聚物調配至黏著劑層。然而,於上述共聚物之調配量較少之情形時,例如於專利文獻1所揭示之貼附劑之情形時,由於調配量較少而導致初始黏力及持續性之黏著性均欠佳之結果,而無法獲得所需之黏著力提高之效果,又,即便於增加了調配量之情形時,尤其是黏著劑層中之水分揮散後之黏著力與貼劑相比亦不可謂足夠。 [解決問題之技術手段]As described above, it is known that in order to improve the adhesion durability of the water-based adhesive, an alkyl acrylate copolymer such as methyl acrylate-2-ethylhexyl acrylate copolymer is blended with the adhesive layer. However, in the case where the amount of the copolymer described above is small, such as the patch disclosed in Patent Document 1, the initial viscosity and the persistent adhesion are not good due to the small amount of the formulation As a result, the desired effect of improving the adhesive force cannot be obtained, and even when the amount of formulation is increased, especially the adhesive force after the water in the adhesive layer has been evaporated is not enough compared with the patch. [Technical means to solve the problem]

本發明人等為了解決上述問題而進行了銳意研究,結果發現,藉由將作為丙烯酸烷基酯系共聚物之如下共聚物調配至上述含水系貼附劑之黏著劑層,而即便於黏著劑層中之水分揮散後黏著力亦不會降低反倒提高,且皮膚刺激性亦較低,從而完成本發明,該共聚物係以如下方式調配而成:調配成為均聚時之玻璃轉移溫度(Tg)為270 K以上之聚合物之單體30~50質量%,並且將成為均聚時之Tg為220 K以下之聚合物之單體以兩單體之合計量成為100質量%之方式調配。The inventors conducted intensive research in order to solve the above-mentioned problems, and as a result, it was found that by blending the following copolymers as alkyl acrylate-based copolymers into the adhesive layer of the above-mentioned water-based adhesive agent, even the adhesive After the water in the layer is swayed, the adhesion will not decrease but will increase, and the skin irritation is also low, thus completing the present invention. The copolymer is formulated in the following manner: the glass transition temperature (Tg) when it is homopolymerized ) Is 30-50% by mass of the monomer of the polymer of 270 K or more, and the monomer of the polymer with a Tg of 220 K or less at the time of homopolymerization is adjusted so that the total amount of the two monomers becomes 100% by mass.

即,本發明係關於一種含水系貼附劑,其係含有支持體、設置於該支持體上之黏著劑層、及剝離襯墊者, 上述黏著劑層係含有下述1)~6)成分作為必須成分而成。 1)丙烯酸系親水性黏著劑; 2)丙烯酸烷基酯系共聚物,其係包含單體A與單體B之單體混合物之共聚物, 上述單體A於使該單體A均聚時會成為玻璃轉移溫度(Tg)為270 K以上之聚合物者, 上述單體B於使該單體B均聚時會成為玻璃轉移溫度(Tg)為220 K以下之聚合物者,且 相對於上述單體混合物之總質量,上述單體A之比率為30質量%以上50質量%以下之比率; 3)有機溶劑; 4)交聯劑; 5)有機酸; 6)水。That is, the present invention relates to a water-based adhesive which contains a support, an adhesive layer provided on the support, and a release liner, The adhesive layer system contains the following components 1) to 6) as essential components. 1) Acrylic hydrophilic adhesive; 2) Alkyl acrylate copolymer, which is a copolymer containing a monomer mixture of monomer A and monomer B, When the above monomer A homopolymerizes the monomer A, it will become a polymer having a glass transition temperature (Tg) of 270 K or more, The above monomer B becomes a polymer having a glass transition temperature (Tg) of 220 K or less when the monomer B is homopolymerized, and Relative to the total mass of the monomer mixture, the ratio of the monomer A is 30% by mass or more and 50% by mass or less; 3) Organic solvents; 4) Crosslinking agent; 5) Organic acids; 6) Water.

並且,根據本發明,進而提供以下之實施態樣。 1.一種上述含水系貼附劑,其中 上述單體A係選自由丙烯酸甲酯、甲基丙烯酸甲酯、甲基丙烯酸乙酯、甲基丙烯酸正丁酯、甲基丙烯酸異丁酯、甲基丙烯酸第三丁酯等(甲基)丙烯酸烷基酯、乙酸乙烯酯、丙烯腈、丙烯醯胺及苯乙烯所組成之群中之至少一種單體, 上述單體B係選自由丙烯酸丁酯、丙烯酸2-乙基己酯、丙烯酸辛酯及丙烯酸異壬酯所組成之群中之至少一種單體。 2.一種上述含水系貼附劑,其中上述單體A係選自由丙烯酸甲酯、甲基丙烯酸甲酯、甲基丙烯酸乙酯及甲基丙烯酸正丁酯所組成之群中之至少一種單體, 上述單體B係選自由丙烯酸2-乙基己酯及丙烯酸丁酯所組成之群中之至少一種單體。 3.一種上述含水系貼附劑,其進而含有有效成分。 [發明之效果]Furthermore, according to the present invention, the following embodiments are further provided. 1. An above-mentioned aqueous patch, wherein The monomer A is selected from (meth)acrylic acid such as methyl acrylate, methyl methacrylate, ethyl methacrylate, n-butyl methacrylate, isobutyl methacrylate, and third butyl methacrylate. At least one monomer in the group consisting of alkyl esters, vinyl acetate, acrylonitrile, acrylamide and styrene, The monomer B is at least one monomer selected from the group consisting of butyl acrylate, 2-ethylhexyl acrylate, octyl acrylate, and isononyl acrylate. 2. The above-mentioned aqueous patch, wherein the above-mentioned monomer A is at least one monomer selected from the group consisting of methyl acrylate, methyl methacrylate, ethyl methacrylate, and n-butyl methacrylate. , The above monomer B is at least one monomer selected from the group consisting of 2-ethylhexyl acrylate and butyl acrylate. 3. The above-mentioned aqueous patch, which further contains an active ingredient. [Effect of invention]

根據本發明,可提供一種含水系貼附劑,其藉由將如下丙烯酸烷基酯系共聚物調配至含水系貼附劑之黏著劑層,而即便於黏著劑層中之水分揮散後亦可維持黏著力,且皮膚刺激性較低,膏體間無附著性,而能夠再貼附於皮膚,該丙烯酸烷基酯系共聚物係包含會成為均聚時之玻璃轉移溫度(Tg)為270 K以上之聚合物之單體A、與會成為均聚時之Tg為220 K以下之聚合物之單體B的單體混合物之共聚物,且相對於該單體混合物之總質量,上述單體A之比率為30質量%以上50質量%以下之比率。According to the present invention, it is possible to provide an aqueous-based patch by blending the following alkyl acrylate-based copolymer into the adhesive layer of the aqueous-based patch, even after the moisture in the adhesive layer has been evaporated Maintains adhesion, low skin irritation, no adhesion between pastes, and can be attached to the skin again. The alkyl acrylate copolymer contains a glass transition temperature (Tg) of 270 when it becomes homopolymerized. A copolymer of a monomer mixture of a polymer of K or more and a monomer mixture of monomer B of a polymer having a Tg of 220 K or less when homopolymerized, and relative to the total mass of the monomer mixture, the above monomers The ratio of A is 30% by mass or more and 50% by mass or less.

如上所述,提出了為了提高含水系貼附劑之黏著力之持續性,將丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂乳液(商品名 NiKasol TS-620,日本電石工業(股))等丙烯酸烷基酯共聚物調配至黏著劑層之方案,或增加其調配量之方案。然而,於在此之前之提案中,即便於增加了共聚物之調配量之情形時,尤其是黏著劑層中之水分揮散後(水揮散後)之黏著力與貼劑相比亦不可謂充分。 本發明人等對於上述問題,著眼於在此之前未被研究之構成丙烯酸烷基酯系共聚物之單體之種類、尤其是其調配比率,對含水時以及乾燥後(水揮散後)之黏著力進行評價。然後,著眼於包含該單體之均聚物之玻璃轉移溫度(Tg),發現藉由採用如下丙烯酸烷基酯系共聚物,而成為即便於該共聚物之調配量較少之情形時,亦不僅含水時黏著力優異就連乾燥時之黏著力亦優異之貼附劑,且成為皮膚刺激性較低之貼附劑,該丙烯酸烷基酯系共聚物係將會成為均聚時之Tg為270 K以上之聚合物之單體、與會成為均聚時之Tg為220 K以下之聚合物之單體組合,並且將均聚物之Tg為270 K以上之單體之調配比率設為所有單體之30質量%以上50質量%以下。 以下,對本發明之含水系貼附劑之構成進行說明。As mentioned above, in order to improve the continuity of the adhesive force of the water-based adhesive, it is proposed to copolymerize the acrylic resin with methyl acrylate and 2-ethylhexyl acrylate (trade name NiKasol TS-620, Japan Carbide Industry Co., Ltd.) It is the solution to adjust the alkyl acrylate copolymer to the adhesive layer, or to increase the preparation amount. However, in the previous proposal, even when the amount of the copolymer is increased, especially after the water in the adhesive layer is swayed (after the water is swayed), the adhesion is not sufficient compared with the patch. . The present inventors have focused on the above-mentioned problems, focusing on the types of monomers constituting the alkyl acrylate copolymer that have not been studied before, especially the blending ratio thereof, and adhesion to water content and after drying (after water is scattered) Evaluation. Then, looking at the glass transition temperature (Tg) of the homopolymer containing the monomer, it was found that by using the following alkyl acrylate copolymer, even when the amount of the copolymer is small, Not only is the adhesive with excellent adhesion when water is included, but also the adhesive with good adhesion when dried, and it becomes an adhesive with low skin irritation. The alkyl acrylate copolymer system will become Tg when homopolymerized. Combination of monomers for polymers above 270 K and monomers for polymers with a Tg of 220 K or less when homopolymerized, and the blending ratio of monomers with a homopolymer Tg of 270 K or more is set to all monomers 30% by mass or more and 50% by mass or less. Hereinafter, the structure of the water-based adhesive agent of the present invention will be described.

本發明之含水系貼附劑(以下,亦簡稱為「貼附劑」)含有支持體、設置於該支持體上之黏著劑層、及剝離襯墊。 上述貼附劑、尤其是包含支持體、與設置於該支持體上之黏著劑層之製劑部分之形狀無特別限定,可根據貼附部位選擇方形(正方形、長方形等)、四邊形(梯形、菱形等)、多邊形、圓形、橢圓形、半圓形、三角形、月牙形、以及組合其等而成之形狀等各種形狀。 再者,貼附劑(尤其是上述製劑部分)之面積可適當決定,例如考慮調配至黏著劑層之有效成分之量等,例如可設為2~300 cm2 之範圍。The water-based adhesive of the present invention (hereinafter, also simply referred to as "adhesive") includes a support, an adhesive layer provided on the support, and a release liner. The shape of the above-mentioned adhesive, especially the preparation part including the support and the adhesive layer provided on the support is not particularly limited, and squares (squares, rectangles, etc.) and quadrilaterals (trapezoids, diamonds) can be selected according to the attachment site Etc.), polygons, circles, ellipses, semi-circles, triangles, crescents, and combinations of these shapes. In addition, the area of the adhesive agent (particularly the above-mentioned preparation part) can be appropriately determined, for example, considering the amount of the active ingredient formulated in the adhesive layer, etc., for example, it can be set in the range of 2 to 300 cm 2 .

[黏著劑層] 本發明之含水系貼附劑之特徵在於:對於其含水系之黏著劑層,除調配下述親水性之丙烯酸系黏著劑以外,亦調配一般構成非水系之丙烯酸系黏著劑之丙烯酸烷基酯系共聚物。 作為一般用於含水系貼附劑之黏著劑層(膏體層)之黏著劑,廣泛使用聚丙烯酸、聚丙烯酸部分中和物、聚丙烯酸鈉、N-乙烯基乙醯胺-丙烯酸鈉共聚樹脂等親水性之丙烯酸系黏著劑。就與上述親水性之丙烯酸系黏著劑親和性較高,可均勻地混練之觀點而言,作為調配至含水系貼附劑之含水系之黏著劑層之非水系黏著劑,較佳為調配丙烯酸系及甲基丙烯酸系之乳液型黏著劑。 再者,本說明書中所謂「丙烯酸烷基酯系共聚物」,旨在包含丙烯酸及甲基丙烯酸之烷基酯兩者,又,「丙烯酸系黏著劑」亦旨在包含丙烯酸系黏著劑與甲基丙烯酸系黏著劑兩者而成。[Adhesive layer] The water-based adhesive of the present invention is characterized in that, for the water-based adhesive layer, in addition to the following hydrophilic acrylic adhesive, the alkyl acrylate generally constituting a non-aqueous acrylic adhesive is also formulated. Department of copolymers. As an adhesive commonly used for the adhesive layer (paste layer) of aqueous adhesives, polyacrylic acid, partially neutralized polyacrylic acid, sodium polyacrylate, N-vinylacetamide-sodium acrylate copolymer resin, etc. are widely used Hydrophilic acrylic adhesive. From the viewpoint of having a high affinity with the above-mentioned hydrophilic acrylic adhesives and being able to uniformly knead them, it is preferable to use acrylic acid as the non-aqueous adhesive to be formulated into the aqueous adhesive layer of the aqueous adhesive. And methacrylic acid emulsion adhesive. In addition, the "alkyl acrylate copolymer" in this specification is intended to include both acrylic acid and methacrylic acid alkyl esters, and the "acrylic adhesive" is also intended to include acrylic adhesives and Based on acrylic adhesives.

<丙烯酸烷基酯系共聚物> 構成非水系之丙烯酸系黏著劑之丙烯酸烷基酯系共聚物(非水系黏著基劑)係包含如下單體之共聚物(於表1列舉單體之一例):作為表現出黏著力之成分之單體,其烷基酯之碳原子數為2~9,且會成為均聚時玻璃轉移溫度(Tg)為-55℃(218 K)以下之聚合物;作為提高凝集力之成分之單體,其會成為均聚時Tg為8~165℃(281~438 K)之聚合物;及進而視需要具有羧基或羥基等成為交聯點等官能基之單體。 本發明中所使用之丙烯酸烷基酯系共聚物係如下單體混合物之共聚物,該單體混合物包含會成為均聚時玻璃轉移溫度(Tg)為270 K以上之聚合物之單體A、與會成為均聚時玻璃轉移溫度(Tg)為220 K以下之聚合物之單體B。上述單體A之均聚物之玻璃轉移溫度Tg之上限值約為500 K,又,上述單體B之均聚物之玻璃轉移溫度Tg之下限值約為200 K。<alkyl acrylate copolymer> The alkyl acrylate copolymer (non-aqueous adhesive base) constituting the non-aqueous acrylic adhesive is a copolymer containing the following monomers (one example of monomers is listed in Table 1): as a component that exhibits adhesion Monomer whose alkyl ester has 2 to 9 carbon atoms and will become a polymer with a glass transition temperature (Tg) of -55°C (218 K) or less during homopolymerization; a monomer that acts as a component to increase cohesion It will become a polymer with a Tg of 8 to 165°C (281 to 438 K) during homopolymerization; and, if necessary, a monomer having a functional group such as a crosslinking point such as a carboxyl group or a hydroxyl group. The alkyl acrylate copolymer used in the present invention is a copolymer of a monomer mixture including a monomer A which will become a polymer having a glass transition temperature (Tg) of 270 K or more during homopolymerization. The monomer B that will become a polymer with a glass transition temperature (Tg) of 220 K or less during homopolymerization. The upper limit of the glass transition temperature Tg of the homopolymer of the above monomer A is about 500 K, and the lower limit of the glass transition temperature Tg of the above homopolymer of the monomer B is about 200 K.

[表1]

Figure 108122813-A0304-0001
[Table 1]
Figure 108122813-A0304-0001

再者,僅使表現出黏著力之單體聚合而成之均聚物雖黏著力較高但機械性強度較弱,一般使用藉由與提高凝集力之單體共聚而使機械性強度得到提高之共聚物作為黏著劑。 如作為上述表1中所示之表現出黏著力之單體所列舉般,本發明中,作為黏著力更高之單體,使用使該單體均聚時(均聚物)之Tg為220 K以下之丙烯酸丁酯、丙烯酸2-乙基己酯、丙烯酸辛酯、丙烯酸異壬酯等。其等之中,較佳為丙烯酸丁酯、丙烯酸2-乙基己酯,其中,可較佳地使用實際用作過醫藥品添加物,且黏著力較高(均聚物之Tg較低)之丙烯酸2-乙基己酯。 又,作為提高凝集力之單體(均聚物之Tg為270 K以上),可列舉表1中所列舉出之單體,其等之中,較佳為丙烯酸甲酯、甲基丙烯酸甲酯、甲基丙烯酸乙酯及甲基丙烯酸正丁酯,本發明中,特佳為機械強度較高,且不會使黏著性顯著降低(均聚物之Tg相對較低)之丙烯酸甲酯。Furthermore, homopolymers obtained by polymerizing only monomers exhibiting adhesion have higher adhesion but weaker mechanical strength, and generally use copolymerization with monomers that increase cohesion to improve mechanical strength The copolymer as an adhesive. As exemplified as the monomer exhibiting adhesive force shown in Table 1 above, in the present invention, as the monomer with higher adhesive force, the Tg when the monomer is homopolymerized (homopolymer) is 220 Butyl acrylate below K, 2-ethylhexyl acrylate, octyl acrylate, isononyl acrylate, etc. Among them, butyl acrylate and 2-ethylhexyl acrylate are preferred. Among them, those which are actually used as additives for medical products can be preferably used, and the adhesion is high (the Tg of the homopolymer is low) 2-ethylhexyl acrylate. In addition, as the monomer for improving cohesion (the homopolymer Tg is 270 K or more), the monomers listed in Table 1 can be cited, and among them, methyl acrylate and methyl methacrylate are preferred , Ethyl methacrylate and n-butyl methacrylate, in the present invention, particularly preferred is methyl acrylate which has high mechanical strength and does not significantly reduce the adhesion (the homopolymer Tg is relatively low).

再者,如先前技術中所列舉般,作為貼附劑所使用之市售之丙烯酸烷基酯系共聚物,有日本電石(股)製造之NiKasol(註冊商標)TS-620(丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂乳液)。丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂乳液係醫藥品添加物規約之收錄品。 本發明人等鑒於在此之前之含水系貼附劑中所使用之NiKasol TS-620(丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂乳液)未獲得所需黏著力之方面、尤其是於來自黏著劑層之水揮散後黏著力降低之方面,而對上述共聚物之共聚比率之變更進行了研究。 並且,於上述共聚物中,對均聚物之Tg成為270 K以上之單體、即丙烯酸甲酯之聚合比率進行各種變更,結果,如下述實施例之結果所示,首次確認到如下情況:使用均聚物之Tg成為270 K以上之單體(丙烯酸甲酯等)之調配量成為30質量%以上之共聚物的系統即便於黏著劑層之水氣揮散時亦可維持黏著力。又,若均聚物之Tg成為270 K以上之單體(丙烯酸甲酯等)之調配量超過50質量%,則乳液凝集、沈澱而變得難以再分散,因此將其上限值設為50質量%以下。In addition, as listed in the prior art, commercially available alkyl acrylate-based copolymers used as adhesives include NiKasol (registered trademark) TS-620 (methyl acrylate- (2-ethylhexyl acrylate copolymer resin emulsion). Methyl acrylate-2-ethylhexyl acrylate copolymer resin emulsion is a catalogue of pharmaceutical additives. The present inventors have considered that NiKasol TS-620 (methyl acrylate-2-ethylhexyl acrylate copolymer resin emulsion) used in the previous aqueous patch has not obtained the required adhesion, especially in With regard to the reduction of the adhesive strength after the water from the adhesive layer was scattered, the change of the copolymerization ratio of the above copolymer was studied. In addition, in the above copolymers, various changes were made to the polymerization ratio of the monomer whose Tg of the homopolymer became 270 K or more, that is, methyl acrylate. As a result, as shown in the results of the following examples, the following were first confirmed: A system using a homopolymer whose Tg becomes a monomer (methyl acrylate, etc.) with a Tg of 270 K or more and a copolymer with a blending amount of 30% by mass or more can maintain the adhesion even when the moisture of the adhesive layer evaporates. In addition, if the Tg of the homopolymer becomes 270 K or more of the monomer (methyl acrylate, etc.), the blending amount exceeds 50% by mass, the emulsion aggregates and precipitates, and it becomes difficult to redisperse, so the upper limit value is set to 50 Mass% or less.

於本發明之含水系貼附劑之黏著劑層中,丙烯酸烷基酯系共聚物之調配量(於乳液之情形時為固形物成分換算量)以含水系貼附劑之黏著劑層之總質量為基準,例如可設為0.1質量%以上30質量%以下、1.0質量%以上15質量%以下、5.0質量%以上10質量%以下。 又,關於與下述丙烯酸系親水性黏著劑之調配比率,例如以質量比率計,可設為丙烯酸烷基酯系共聚物:丙烯酸系親水性黏著劑=10:1~1:10、丙烯酸烷基酯系共聚物:丙烯酸系親水性黏著=5:1~1:5、丙烯酸烷基酯系共聚物:丙烯酸系親水性黏著=3:1~1:2、丙烯酸烷基酯系共聚物:丙烯酸系親水性黏著=2:1~1:1等。In the adhesive layer of the aqueous adhesive of the present invention, the formulation amount of the alkyl acrylate copolymer (in the case of an emulsion is the amount of solid content conversion) is the total amount of the adhesive layer of the aqueous adhesive The mass is based on, for example, 0.1 mass% or more and 30 mass% or less, 1.0 mass% or more and 15 mass% or less, 5.0 mass% or more and 10 mass% or less. In addition, the formulation ratio with the following acrylic hydrophilic adhesive can be set as an alkyl acrylate copolymer in terms of mass ratio, for example: acrylic hydrophilic adhesive = 10:1 to 1:10, alkyl acrylate Base ester copolymer: Acrylic hydrophilic adhesive = 5:1 to 1:5, alkyl acrylate copolymer: Acrylic hydrophilic adhesive = 3:1 to 1:2, alkyl acrylate copolymer: Acrylic hydrophilic adhesion = 2:1:1 to 1:1, etc.

<有效成分> 本發明之含水系貼附劑中之黏著劑層任意地含有有效成分。作為未含有有效成分之情形時之本發明之含水系貼附劑之用途,可利用於蟹足腫狀之皮膚之防護材、或保護老繭或水泡等之緩衝材等。 於黏著劑層含有有效成分之情形時,含有生理活性物質。所謂生理活性物質,只要為具有經皮吸收性,且於投予至體內時表現藥理活性者即可,並無特別限定,可為水溶性物質亦可為脂溶性物質。 作為生理活性物質,例如可列舉:聯苯乙酸、氟比洛芬、雙氯芬酸、雙氯芬酸鈉、水楊酸甲酯、水楊酸二醇酯(水楊酸乙二醇酯)、吲哚美辛、酮洛芬、布洛芬等非類固醇系抗炎劑或其等之酯;苯海拉明、氯芬尼拉明等抗組胺劑;阿斯匹靈、乙醯胺酚、布洛芬、洛索洛芬鈉等鎮痛劑;利多卡因、狄布卡因等局部麻醉劑;氯化琥珀膽鹼等肌肉鬆弛劑;克黴唑等抗真菌劑;氯壓定等降壓劑;硝化甘油、硝酸異山梨酯等血管舒張劑;維生素A、維生素E(生育酚)、乙酸維生素E酯、維生素K、奧托硫胺、丁酸核黃素等維生素類、前列腺素類;莨菪胺、芬太尼、辣椒萃取物、壬酸十一碳醯胺、辣椒鹼、l-薄荷腦、dl-樟腦等。生理活性物質可單獨使用1種,亦可組合2種以上使用。<active ingredient> The adhesive layer in the aqueous patch of the present invention optionally contains an active ingredient. As an application of the aqueous patch of the present invention when no active ingredient is contained, it can be used as a protective material for swollen crab foot skin, a buffer material for protecting calluses, blisters, etc. When the adhesive layer contains active ingredients, it contains physiologically active substances. The physiologically active substance is not particularly limited as long as it has transdermal absorbability and exhibits pharmacological activity when administered into the body, and it may be a water-soluble substance or a fat-soluble substance. Examples of the physiologically active substance include biphenylacetic acid, flurbiprofen, diclofenac, diclofenac sodium, methyl salicylate, glycol salicylate (glycol salicylate), indomethacin, Non-steroidal anti-inflammatory agents such as ketoprofen and ibuprofen or their esters; antihistamines such as diphenhydramine and chlorfeniramine; aspirin, acetaminophen, ibuprofen, loxolol Analgesics such as fen sodium; local anesthetics such as lidocaine and dibucaine; muscle relaxants such as succinylcholine chloride; antifungal agents such as clotrimazole; antihypertensive agents such as clonidine; nitroglycerin, isosorbide dinitrate Vasodilators such as esters; vitamins A, vitamin E (tocopherol), vitamin E acetate, vitamin K, otothiamin, riboflavin and other vitamins, prostaglandins; scopolamine, fentanyl, chili Extract, undecanoic acid nonanoic acid, capsaicin, l-menthol, dl-camphor etc. The physiologically active substance may be used alone or in combination of two or more.

上述有效成分可根據其種類而適當決定調配量,例如以含水系貼附劑之黏著劑層之總質量為基準,可設為0.1質量%以上30質量%以下,或者0.5質量%以上15質量%以下。The above-mentioned effective ingredient can be appropriately determined according to the type of formulation, for example, based on the total mass of the adhesive layer of the water-based adhesive, it can be set to 0.1 mass% or more and 30 mass% or less, or 0.5 mass% or more and 15 mass% the following.

<丙烯酸系親水性黏著劑> 本發明之含水系貼附劑之黏著劑層含有丙烯酸系親水性黏著劑。 作為上述丙烯酸系親水性黏著劑,可列舉水溶性之(甲基)丙烯酸系聚合物。水溶性(甲基)丙烯酸系聚合物係使含有具有水溶性之官能基(親水性基)之含(甲基)丙烯醯基之單體聚合所獲得者,且藉由與水一併調配至黏著劑層而發揮黏著性。水溶性(甲基)丙烯酸系聚合物例如可列舉:聚丙烯酸、聚丙烯酸之中和物等均聚物;N-乙烯基乙醯胺-丙烯酸鈉共聚樹脂等共聚物。 上述聚丙烯酸中和物可為聚丙烯酸完全中和物,亦可為聚丙烯酸部分中和物,亦可為其等之混合物。所謂聚丙烯酸中和物,意指聚丙烯酸鹽,例如可使用鈉鹽、鉀鹽、鈣鹽、銨鹽等。<Acrylic hydrophilic adhesive> The adhesive layer of the aqueous adhesive of the present invention contains an acrylic hydrophilic adhesive. Examples of the acrylic hydrophilic adhesive include water-soluble (meth)acrylic polymers. The water-soluble (meth)acrylic polymer is obtained by polymerizing a (meth)acryloyl group-containing monomer having a water-soluble functional group (hydrophilic group), and is formulated together with water to Adhesive layer to achieve adhesion. Examples of the water-soluble (meth)acrylic polymer include homopolymers such as polyacrylic acid and polyacrylic acid neutrals; and copolymers such as N-vinylacetamide-sodium acrylate copolymer resin. The polyacrylic acid neutralized product may be a polyacrylic acid completely neutralized product, a polyacrylic acid partially neutralized product, or a mixture thereof. The term "polyacrylic acid neutralized product" refers to polyacrylate. For example, sodium salt, potassium salt, calcium salt, ammonium salt and the like can be used.

丙烯酸系親水性黏著劑之調配量以含水系貼附劑之黏著劑層之總質量為基準,例如可設為0.1質量%以上10質量%以下、1質量%以上8質量%以下。The blending amount of the acrylic hydrophilic adhesive is based on the total mass of the adhesive layer of the water-based adhesive, and it can be, for example, 0.1 mass% or more and 10 mass% or less, and 1 mass% or more and 8 mass% or less.

<有機溶劑> 調配至本發明之含水系貼附劑之黏著劑層之有機溶劑可具有如下作用,即輔助藥物等有效成分之溶解,又,防止有效成分自黏著劑層析出。作為此種有機溶劑(溶解助劑),可列舉:克羅米通;N-甲基-2-吡咯啶酮;聚乙二醇400(聚乙二醇)、聚丁二醇等聚伸烷基二醇;己二酸二乙酯、己二酸二異丙酯、癸二酸二乙酯、癸二酸二異丙酯、肉豆蔻酸異丙酯、棕櫚酸異丙酯、油酸油脂等脂肪酸酯;聚氧伸烷基脂肪酸酯等山梨醇酐酯類;1,3-丁二醇等多元醇;二甲基甲醯胺;二甲基亞碸等。該等可單獨地使用一種,或者組合2種以上使用。<Organic solvent> The organic solvent formulated to the adhesive layer of the aqueous adhesive of the present invention may have the following effects, that is, to dissolve the effective ingredients such as drugs, and to prevent the effective ingredients from being chromatized from the adhesive. Examples of such organic solvents (dissolution aids) include: crotamiton; N-methyl-2-pyrrolidone; polyalkylene glycols such as polyethylene glycol 400 (polyethylene glycol) and polybutylene glycol Diol; diethyl adipate, diisopropyl adipate, diethyl sebacate, diisopropyl sebacate, isopropyl myristate, isopropyl palmitate, oleic oil and fat Etc. fatty acid esters; sorbitan esters such as polyoxyalkylene fatty acid esters; polyhydric alcohols such as 1,3-butanediol; dimethylformamide; dimethyl sulfoxide, etc. These can be used alone or in combination of two or more.

有機溶劑之調配量以含水系貼附劑之黏著劑層之總質量為基準,例如可設為0.1質量%以上20質量%以下。The blending amount of the organic solvent is based on the total mass of the adhesive layer of the water-based adhesive, and can be set to, for example, 0.1% by mass or more and 20% by mass or less.

<交聯劑> 作為調配至本發明之含水系貼附劑之黏著劑層之交聯劑,可列舉多價金屬鹽,其中可列舉含鋁之多價金屬化合物。作為一例,可列舉:氫氧化鋁、氫氧化鋁鎂等氫氧化物;氯化鋁、硫酸鋁、硫酸鋁鉀、甘氨酸鋁(二羥基鋁胺基縮醛)、二羥基鋁胺基乙酸鹽、合成矽酸鋁、乾燥氫氧化鋁凝膠、高嶺土、硬脂酸鋁等無機或有機酸之正鹽或其等之鹼性鹽;鋁礬等複合鹽;鋁酸納等鋁酸鹽;無機性鋁錯鹽及有機性鋁螯合化合物;合成鋁碳酸鎂、鋁矽酸鎂、矽酸鋁鎂等多價金屬化合物,其等可單獨使用或組合2種以上使用。<Crosslinking agent> Examples of the crosslinking agent formulated in the adhesive layer of the aqueous adhesive of the present invention include polyvalent metal salts, and among them, polyvalent metal compounds containing aluminum. As an example, hydroxides such as aluminum hydroxide and aluminum magnesium hydroxide; aluminum chloride, aluminum sulfate, aluminum potassium sulfate, aluminum glycinate (dihydroxy aluminum amino acetal), dihydroxy aluminum amino acetate, Synthetic positive salts of inorganic or organic acids such as aluminum silicate, dried aluminum hydroxide gel, kaolin, aluminum stearate or their alkaline salts; composite salts such as aluminum alum; aluminates such as sodium aluminate; inorganic Aluminum complex salts and organic aluminum chelate compounds; synthetic polyvalent metal compounds such as aluminum magnesium carbonate, aluminum magnesium silicate, aluminum magnesium silicate, etc., which can be used alone or in combination of two or more.

關於交聯劑之調配量,若考慮黏著劑對皮膚之殘留或可成為貼合性之原因之一之交聯度而適當選擇即可。以含水系貼附劑之黏著劑層之總質量為基準,例如可列舉0.01質量%以上6.0質量%以下、0.01質量%以上4.0質量%以下、或者0.01質量%以上2.0質量%以下之範圍。The formulation amount of the cross-linking agent may be appropriately selected considering the residual of the adhesive on the skin or the degree of cross-linking which may be one of the reasons for the conformability. Based on the total mass of the adhesive layer of the water-based adhesive, for example, a range of 0.01% by mass or more and 6.0% by mass or less, 0.01% by mass or more and 4.0% by mass or less, or 0.01% by mass or more and 2.0% by mass or less can be cited.

<有機酸> 作為調配至本發明之含水系貼附劑之黏著劑層之有機酸,可列舉:檸檬酸、乳酸、酒石酸、葡萄糖酸、乙醇酸、蘋果酸、富馬酸、甲磺酸、馬來酸、乙酸等,其等可單獨使用或組合2種以上使用。 關於有機酸之調配量,以含水系貼附劑之黏著劑層之總質量為基準,例如可設為0.01質量%以上5質量%以下之範圍。<Organic acid> Examples of the organic acid formulated in the adhesive layer of the aqueous adhesive of the present invention include citric acid, lactic acid, tartaric acid, gluconic acid, glycolic acid, malic acid, fumaric acid, methanesulfonic acid, maleic acid, Acetic acid and the like can be used alone or in combination of two or more. Regarding the amount of organic acid to be formulated, based on the total mass of the adhesive layer of the water-based adhesive, for example, it can be set in the range of 0.01% by mass or more and 5% by mass or less.

<水> 如上所述,本發明之含水系貼附劑係於黏著劑層中含有水(水分)者。本說明書中,所謂黏著劑層所含有之「水」,不僅包含形成黏著劑層時作為水另行添加者,亦包含作為乳液或水溶液等形態所含有之水。水之調配量無特別限定,以含水系貼附劑之黏著劑層之總質量為基準,例如可設為10質量%以上90質量%以下、15質量%以上70質量%以下、20質量%以上50質量%以下之範圍。再者,該水分調配量係貼附劑製備時、或者貼附劑貼附前之值,於伴隨貼附之經過而水自黏著劑層揮散之情形時,並不限於此。<Water> As described above, the water-based adhesive of the present invention contains water (moisture) in the adhesive layer. In this specification, the "water" contained in the adhesive layer includes not only those added separately as water when forming the adhesive layer, but also water contained in the form of an emulsion or an aqueous solution. The amount of water to be mixed is not particularly limited, and can be set to 10% by mass or more, 90% by mass or less, 15% by mass or more, 70% by mass or less, or 20% by mass based on the total mass of the adhesive layer of the water-based adhesive. 50% by mass or less. In addition, the water blending amount is the value at the time of preparation of the adhesive agent or before the application of the adhesive agent, and it is not limited to this when the water evaporates from the adhesive layer as the adhesive agent passes.

<其他任意成分> 於本發明之含水系貼附劑之黏著劑層中亦可調配水溶性高分子化合物、界面活性劑、濕潤劑、穩定劑、抗氧化劑、無機粉體、著色劑、香料、防腐劑等一般可調配至先前之含水系貼附劑(敷劑)或非水系貼附劑(貼劑)中之黏著劑層之成分作為他任意成分。該等任意成分可分別單獨使用或組合2種以上使用。<Other arbitrary ingredients> Water-soluble polymer compounds, surfactants, wetting agents, stabilizers, antioxidants, inorganic powders, colorants, fragrances, preservatives, etc. can also be formulated in the adhesive layer of the aqueous adhesive of the present invention. The ingredients formulated in the adhesive layer in the previous aqueous-based patch (dressing) or non-aqueous-based patch (patch) are used as any other ingredients. These arbitrary components can be used individually or in combination of 2 or more types.

<水溶性高分子化合物> 作為水溶性高分子化合物,例如可列舉:明膠、瓊脂、聚乙烯醇、聚乙烯吡咯啶酮、碳酸丙二酯、羧甲基纖維素、羧甲基纖維素鈉、羥丙基纖維素、羥丙基甲基纖維素、羥乙基纖維素、甲基纖維素、海藻酸鈉、馬來酸酐共聚物、角叉菜膠。其等可單獨使用1種,或適當組合2種以上使用。 關於水溶性高分子化合物之調配量,通常以含水系貼附劑之黏著劑層之總質量為基準,例如可設為1.0質量%以上30質量%以下、3.0質量%以上20質量%以下、或者5.0質量%以上20質量%以下之範圍。<Water-soluble polymer compound> Examples of the water-soluble polymer compound include gelatin, agar, polyvinyl alcohol, polyvinylpyrrolidone, propylene carbonate, carboxymethyl cellulose, sodium carboxymethyl cellulose, hydroxypropyl cellulose, and hydroxy Propyl methyl cellulose, hydroxyethyl cellulose, methyl cellulose, sodium alginate, maleic anhydride copolymer, carrageenan. These can be used alone or in combination of two or more. The formulation amount of the water-soluble polymer compound is usually based on the total mass of the adhesive layer of the water-based adhesive, for example, it can be set to 1.0% by mass or more and 30% by mass or less, 3.0% by mass or more and 20% by mass or less, or 5.0% by mass or more and 20% by mass or less.

<界面活性劑> 作為界面活性劑,例如可列舉:聚氧乙烯單月桂酸酯、聚氧乙烯單硬脂酸酯、聚氧乙烯單油酸酯、聚乙二醇二硬脂酸酯、聚乙二醇二油酸酯、聚丙二醇二油酸酯等聚氧乙烯脂肪酸酯;山梨醇酐單辛酸酯、山梨醇酐單月桂酸酯、山梨醇酐單肉豆蔻酸酯、山梨醇酐單棕櫚酸酯、山梨醇酐單硬脂酸酯、山梨醇酐二硬脂酸酯、山梨醇酐三硬脂酸酯、山梨醇酐單油酸酯、山梨醇酐三油酸酯、山梨醇酐單倍半油酸酯、及其等之環氧乙烷加成物等山梨醇酐脂肪酸酯;聚氧乙烯山梨醇酐單月桂酸酯、聚氧乙烯山梨醇酐單棕櫚酸酯、聚氧乙烯山梨醇酐單硬脂酸酯、聚氧乙烯山梨醇酐三硬脂酸酯、聚氧乙烯山梨醇酐單油酸酯、聚氧乙烯山梨醇酐三油酸酯、聚氧乙烯山梨醇酐三異硬脂酸酯等聚氧乙烯山梨醇酐脂肪酸酯;聚氧乙烯十二烷基醚(聚氧乙烯月桂醚)、聚氧伸烷基月桂醚、聚氧乙烯十三烷基醚、聚氧伸烷基十三烷基醚、聚氧乙烯十四烷基醚、聚氧乙烯十六烷基醚、聚氧乙烯油醚、聚氧乙烯硬脂基醚、聚氧乙烯山萮醚、聚氧乙烯-2-乙基己基醚、聚氧乙烯異癸基醚等聚氧乙烯烷基醚;聚氧乙烯苯乙烯化苯醚、聚氧乙烯壬基苯醚、聚氧乙烯二苯乙烯化苯醚、聚氧乙烯三苄基苯醚等聚氧乙烯烷基苯酚醚;單硬脂酸甘油酯、單油酸甘油酯等甘油脂肪酸酯;聚乙二醇、聚氧乙烯氫化蓖麻油、聚氧乙烯蓖麻油、卵磷脂等非離子性界面活性劑。其等可單獨使用1種,或適當組合2種以上使用。 關於該等界面活性劑之調配量,以含水系貼附劑之黏著劑層之總質量為基準,例如可設為0.001質量%以上10質量%以下、0.01質量%以上5質量%以下之範圍。<surfactant> Examples of the surfactant include polyoxyethylene monolaurate, polyoxyethylene monostearate, polyoxyethylene monooleate, polyethylene glycol distearate, and polyethylene glycol dioleate. Polyoxyethylene fatty acid esters such as acid esters and polypropylene glycol dioleate; sorbitan monocaprylate, sorbitan monolaurate, sorbitan monomyristate, sorbitan monopalmitate, Sorbitan monostearate, sorbitan distearate, sorbitan tristearate, sorbitan monooleate, sorbitan trioleate, sorbitan sesqui oil Acid esters, and other ethylene oxide adducts and other sorbitan fatty acid esters; polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan Monostearate, polyoxyethylene sorbitan tristearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan trioleate, polyoxyethylene sorbitan triisostearate Polyoxyethylene sorbitan fatty acid esters such as esters; polyoxyethylene lauryl ether (polyoxyethylene lauryl ether), polyoxyalkylene lauryl ether, polyoxyethylene tridecyl ether, polyoxyalkylene Tridecyl ether, polyoxyethylene tetradecyl ether, polyoxyethylene cetyl ether, polyoxyethylene oleyl ether, polyoxyethylene stearyl ether, polyoxyethylene behenyl ether, polyoxyethylene- 2-ethylhexyl ether, polyoxyethylene isodecyl ether and other polyoxyethylene alkyl ethers; polyoxyethylene styrenated phenyl ether, polyoxyethylene nonyl phenyl ether, polyoxyethylene distyrenated phenyl ether, polyoxyethylene Polyoxyethylene alkyl phenol ethers such as oxyethylene tribenzyl phenyl ether; glycerol fatty acid esters such as glyceryl monostearate and glyceryl monooleate; polyethylene glycol, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor Nonionic surfactants such as sesame oil and lecithin. These can be used alone or in combination of two or more. The formulation amount of these surfactants is based on the total mass of the adhesive layer of the water-based adhesive, and can be set, for example, in the range of 0.001 mass% or more and 10 mass% or less, and 0.01 mass% or more and 5 mass% or less.

<濕潤劑> 為了抑制經時性之水分之蒸發,可將濕潤劑(亦稱為保濕劑)調配至本發明之含水系貼附劑之黏著劑層中。作為濕潤劑,例如可列舉:濃甘油、D-山梨糖醇、乙二醇、丙二醇、聚乙二醇、聚丙二醇、液態石蠟、1,3-丙二醇、1,4-丁二醇、麥芽糖醇、木糖醇等多元醇。其等可單獨使用1種,或適當組合2種以上使用。 關於濕潤劑之調配量,通常以含水系貼附劑之黏著劑層之總質量為基準,例如可設為1.0質量%以上70質量%以下、5.0質量%以上60質量%以下、或者10質量%以上60質量%以下之範圍。<wetting agent> In order to suppress the evaporation of water over time, a wetting agent (also known as a humectant) can be formulated into the adhesive layer of the aqueous adhesive of the present invention. Examples of the wetting agent include concentrated glycerin, D-sorbitol, ethylene glycol, propylene glycol, polyethylene glycol, polypropylene glycol, liquid paraffin, 1,3-propanediol, 1,4-butanediol, and maltitol , Xylitol and other polyols. These can be used alone or in combination of two or more. The formulation amount of the wetting agent is usually based on the total mass of the adhesive layer of the water-based adhesive, for example, it can be set to 1.0% by mass or more, 70% by mass or less, 5.0% by mass or more, 60% by mass or less, or 10% by mass Above 60% by mass range.

<穩定劑> 為了提高上述有效成分等對於光(尤其是紫外線)、熱或氧之保存穩定性,可將穩定劑調配至本發明之含水系貼附劑之黏著劑層。 作為穩定劑,例如可列舉:依地酸鈉依地酸鈉(乙二胺四乙酸2鈉鹽);二丁基羥基甲苯(BHT)等抗氧化劑;苯甲醯甲烷衍生物等紫外線吸附劑等。 關於穩定劑之調配量,通常以含水系貼附劑之黏著劑層之總質量為基準,例如可設為0.01質量%以上1質量%以下之範圍。<Stabilizer> In order to improve the storage stability of the above active ingredients, etc. against light (especially ultraviolet rays), heat or oxygen, a stabilizer may be formulated in the adhesive layer of the aqueous adhesive of the present invention. Examples of stabilizers include sodium edetate and sodium edetate (ethylenediaminetetraacetic acid 2 sodium salt); antioxidants such as dibutylhydroxytoluene (BHT); and ultraviolet adsorbents such as benzoylmethane derivatives. . The formulation amount of the stabilizer is usually based on the total mass of the adhesive layer of the water-based adhesive, and it can be set, for example, in the range of 0.01% by mass or more and 1% by mass or less.

<無機粉體> 作為無機粉體,可調配碳酸鈣、碳酸鎂、矽酸鹽、氧化鋅、氧化鈦、硫酸鎂、硫酸鈣等。<Inorganic powder> As inorganic powder, calcium carbonate, magnesium carbonate, silicate, zinc oxide, titanium oxide, magnesium sulfate, calcium sulfate, etc. can be formulated.

[支持體] 作為本發明之含水系貼附劑所使用之支持體,可列舉膜、不織布、日本紙、棉布、編織布、織布、不織布與膜之層壓複合體等具有柔軟性之支持體。該等支持體較佳為可與皮膚密接,且可追隨於皮膚之活動之程度之柔軟材質,並且可抑制於長時間貼附後產生皮膚之斑疹等之材質。作為該等支持體之材質,例如可列舉將聚乙烯、聚丙烯、聚對苯二甲酸乙二酯、聚對苯二甲酸丁二酯、聚萘二甲酸乙二酯、聚苯乙烯、尼龍、棉、乙酸嫘縈、嫘縈、嫘縈/聚對苯二甲酸乙二酯複合體、聚丙烯腈、聚乙烯醇、丙烯酸系聚胺基甲酸酯、酯系聚胺基甲酸酯、醚系聚胺基甲酸酯、苯乙烯-異戊二烯-苯乙烯共聚物、苯乙烯-丁二烯-苯乙烯共聚物、苯乙烯-乙烯-丙烯-苯乙烯共聚物、苯乙烯-丁二烯橡膠、乙烯-乙酸乙烯酯共聚物、塞璐芬等作為必須成分者。[Support] Examples of the support used in the aqueous patch of the present invention include flexible supports such as films, nonwoven fabrics, Japanese paper, cotton cloth, woven fabrics, woven fabrics, and laminated composites of nonwoven fabrics and films. The support is preferably a soft material that can be in close contact with the skin and can follow the degree of skin activity, and can suppress the occurrence of skin rashes and the like after long-term attachment. Examples of the material of these supports include polyethylene, polypropylene, polyethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, polystyrene, nylon, Cotton, acetic acid rayon, rayon, rayon/polyethylene terephthalate composite, polyacrylonitrile, polyvinyl alcohol, acrylic polyurethane, ester polyurethane, ether Polyurethane, styrene-isoprene-styrene copolymer, styrene-butadiene-styrene copolymer, styrene-ethylene-propylene-styrene copolymer, styrene-butadiene Vinyl rubber, ethylene-vinyl acetate copolymer, seruphen, etc. are essential ingredients.

又,布類等支持體藉由利用著色劑著色成膚色等色調,可減少貼附時與皮膚之顏色之不同。又,就貼附狀態下易使皮膚之色調透出之觀點而言,可採用透明性優異之塑膠膜之形態。In addition, cloths and other supports can be colored into skin tones and the like by using coloring agents, which can reduce the difference in color from the skin when they are attached. In addition, from the viewpoint that the color tone of the skin is easily revealed in the attached state, a form of a plastic film with excellent transparency can be adopted.

支持體之厚度通常為5 μm至1 mm左右。於支持體為布類之情形時,其厚度較佳為50 μm~1 mm,更佳為100~800 μm,進而較佳為200~700 μm。於支持體為塑膠膜之情形時,其厚度較佳為10~300 μm,更佳為12~200 μm,進而較佳為15~150 μm。於支持體之厚度極薄為5 μm~30 μm左右之情形時,若於形成於支持體上之黏著劑層相反之面上設置能夠剝離之承載膜層,則作為貼附劑之操作性提高,故而較佳。但,若支持體之厚度小於5 μm,則有時貼附劑之強度或操作性下降而對皮膚之貼附變得困難,或因與其他構件等接觸而破損,或因入浴等與水接觸而短時間內自皮膚剝離等。又,若支持體之厚度過大(超過1 mm),則貼附劑變得不易追隨於皮膚之活動,易於貼附劑之邊緣部形成剝落起點,因此有短時間內自皮膚剝離,或貼附中之不適感增加之虞。 再者,於支持體為膜之情形時,亦可以提高黏著劑與支持體之抓固性為目的,於支持體之單面或兩面進行噴砂處理、電暈處理等處理。 又,為了容易自包裝材料中取出,亦可於支持體之單面或兩面利用噴砂以外之方法設置凹凸。The thickness of the support is usually about 5 μm to 1 mm. When the support is cloth, the thickness is preferably 50 μm to 1 mm, more preferably 100 to 800 μm, and still more preferably 200 to 700 μm. When the support is a plastic film, the thickness is preferably 10 to 300 μm, more preferably 12 to 200 μm, and still more preferably 15 to 150 μm. In the case where the thickness of the support is extremely thin, about 5 μm to 30 μm, if a peelable carrier film layer is provided on the opposite side of the adhesive layer formed on the support, the operability as an adhesive is improved , So it is better. However, if the thickness of the support is less than 5 μm, the strength or operability of the patch may be reduced and it may become difficult to stick to the skin, or may be damaged due to contact with other members, or may be in contact with water due to bathing, etc. And peel off from the skin in a short time. In addition, if the thickness of the support is too large (more than 1 mm), the patch becomes difficult to follow the movement of the skin, and the edge of the patch is easy to form a starting point for peeling, so there is a short time to peel from the skin, or the patch is in progress Increased discomfort. In addition, when the support is a film, the adhesive and the support can be improved for the purpose of sandblasting, corona treatment, etc. on one or both sides of the support. In addition, for easy removal from the packaging material, irregularities may be provided on one side or both sides of the support by a method other than sandblasting.

[剝離襯墊] 作為本發明之含水系貼附劑所使用之剝離襯墊(亦稱為剝離層、剝離紙),較佳為不易吸收、吸附黏著劑層中之藥物等之材質,可使用於貼附劑之技術領域中慣用之材質。 例如可列舉:聚酯(聚對苯二甲酸乙二酯、聚對苯二甲酸丁二酯、聚萘二甲酸乙二酯等)、聚丙烯(未延伸、延伸等)、聚乙烯、聚胺基甲酸酯、聚氯乙烯、聚苯乙烯等塑膠膜;道林紙、玻璃紙、羊皮紙、牛皮紙等紙或合成紙;向上述塑膠膜、紙或合成紙、合成纖維等塗佈聚矽氧樹脂或氟樹脂等具有剝離性能之剝離劑而成之剝離加工紙;鋁箔;將該等膜、片材進行各種積層而成之層壓加工紙、及向該層壓加工紙塗佈剝離劑而成之層壓剝離加工紙等無色或著色之片材。再者,剝離材料亦能夠設置凹凸以便易從包裝材料中取出。 該等剝離襯墊之厚度無特別限定,通常為10 μm~1 mm,例如為20 μm~500 μm,較佳為40 μm~200 μm之範圍。 剝離材料之形狀可設為方形、矩形、圓形等,可根據需要製成使角變圓之形狀。其大小可設為與上述貼附材料中之支持體之大小相同之形狀,或較之稍大。剝離材料可由1片或分割之複數片所構成,其切口可由直線、波浪線、縫線狀所構成,亦可設為剝離材料彼此之一部分重疊之狀態。[Release liner] As the release liner (also called release layer and release paper) used in the water-based adhesive of the present invention, it is preferably a material that is not easily absorbed and absorbs drugs in the adhesive layer, and can be used for the adhesive Material commonly used in the technical field. For example, polyester (polyethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, etc.), polypropylene (unextended, extended, etc.), polyethylene, polyamine Carbamate, PVC, polystyrene and other plastic films; Dowling paper, cellophane, parchment, kraft paper and other paper or synthetic paper; apply polysiloxane resin to the above plastic film, paper or synthetic paper, synthetic fiber, etc. Peeling paper made of peeling agent with fluororesin or other peeling properties; aluminum foil; laminated paper made by laminating these films and sheets in various layers; and applying peeling agent to the laminated paper Colorless or colored sheets such as laminated peeling paper. Furthermore, the peeling material can also be provided with concavities and convexities to facilitate removal from the packaging material. The thickness of the release liner is not particularly limited, and it is usually 10 μm to 1 mm, for example, 20 μm to 500 μm, preferably 40 μm to 200 μm. The shape of the peeling material can be set as square, rectangle, circle, etc., and can be made into a shape with rounded corners as required. The size can be set to the same shape as the size of the support in the above-mentioned attachment material, or slightly larger. The peeling material may be formed by one piece or a plurality of divided pieces, and the cutout may be formed by a straight line, a wavy line, or a suture shape, or a state where part of the peeling materials overlap each other.

[含水系貼附劑之製造方法] 本發明之含水系貼附劑可使用先前公知之方法製造。例如作為一例,能夠經以下i)或ii)之步驟進行製造。 i)向支持體上塗佈黏著劑層形成組合物而形成黏著劑層之步驟;及將形成於支持體上之黏著劑層與剝離襯墊貼合之步驟。 ii)向剝離襯墊上塗佈黏著劑層形成組合物而形成黏著劑層之步驟;及將形成於於剝離襯墊上之黏著劑層與支持體貼合之步驟。 再者,上述黏著劑層之厚度無特別限定,通常為10 μm至1000 μm,例如可設為20 μm至800 μm左右。[Manufacturing method of water-based adhesive agent] The water-based patch of the present invention can be produced using a previously known method. For example, as an example, it can be manufactured through the following steps i) or ii). i) A step of applying an adhesive layer forming composition to the support to form an adhesive layer; and a step of attaching the adhesive layer formed on the support to the release liner. ii) A step of applying an adhesive layer forming composition to the release liner to form an adhesive layer; and a step of attaching the adhesive layer formed on the release liner to the support. In addition, the thickness of the adhesive layer is not particularly limited, but is usually 10 μm to 1000 μm, for example, it can be set to about 20 μm to 800 μm.

所謂上述黏著劑層形成組合物,係含有上述黏著劑層所含有之各種成分:有效成分、丙烯酸系親水性黏著劑、丙烯酸烷基酯系共聚物、有機溶劑、交聯劑、有機酸及水,進而可含有其他任意成分之半固體狀組合物。The above-mentioned adhesive layer-forming composition contains various components contained in the above-mentioned adhesive layer: active ingredient, acrylic hydrophilic adhesive, alkyl acrylate copolymer, organic solvent, crosslinking agent, organic acid and water In addition, it may contain a semi-solid composition of other optional components.

再者,本發明之含水系貼附劑之特徵在於含水時以及乾燥時(水揮散後)之黏著力得到維持,又,係皮膚刺激性亦較低之貼附劑。 此處,皮膚刺激性例如可藉由基於崔氏實驗法之皮膚一次刺激性指數(P.I.I.)之個體平均值(平均P.I.I.)進行評價,本發明之貼附劑例如可設為1.40以下。 上述所謂基於崔氏實驗法之皮膚一次刺激性指數(P.I.I.)(Primary Irritation Index),係使用兔子之病變之評價方法。具體而言,將檢體(被實驗物質)貼附於兔子之背部,於特定時間後除去檢體,其後對經過特定時間後之貼附部位之反應(觀察紅斑之狀態與浮腫之大小)以0~4之5階段進行評價,且係以2個評價值之合計值(於判定時間為複數個之情形時為其平均值)之形式所表示之值,考慮到所評價之個體差,算出個體平均值(平均P.I.I.)而進行評價。 本發明中,於將檢體(含水系貼附劑)貼附24小時後,去除檢體,其後,經過特定時間後對貼附部位進行觀察,實施刺激反應之評分,基於去除後30分鐘後及24小時後之刺激反應之評分,算出平均P.I.I.,而對皮膚刺激性進行評價。 [實施例]In addition, the water-based adhesive agent of the present invention is characterized in that the adhesive force is maintained when it is hydrated and when it is dried (after water is scattered), and it is also an adhesive agent that has low skin irritation. Here, the skin irritation can be evaluated by, for example, the individual average value (average P.I.I.) of the skin primary irritation index (P.I.I.) based on the Chui test method, and the patch of the present invention can be set to, for example, 1.40 or less. The so-called Primary Irritation Index (P.I.I.) (Primary Irritation Index) based on the Choi's test method is an evaluation method using a rabbit's lesion. Specifically, the specimen (substance to be tested) is attached to the back of the rabbit, and the specimen is removed after a certain time, and then the reaction to the attachment site after a certain time (observing the state of erythema and the size of puffiness) The evaluation is carried out in 5 stages from 0 to 4, and the value is expressed in the form of the total value of the 2 evaluation values (the average value when the judgment time is plural), taking into account the individual differences evaluated, The individual average value (average PII) was calculated and evaluated. In the present invention, after the specimen (aqueous patch) is attached for 24 hours, the specimen is removed, and then, after a certain period of time, the attachment site is observed, and a stimulus response score is performed based on 30 minutes after removal After scoring the irritation response after 24 hours, the average PII was calculated, and the skin irritation was evaluated. [Example]

以下,列舉實施例,對本發明進一步詳細地進行說明,但本發明並不受該等實施例限定。Hereinafter, the present invention will be described in further detail with examples, but the present invention is not limited to these examples.

<貼附劑之製作> 按照以下之順序製造實施例及比較例之貼附劑。<Production of adhesive patch> The adhesives of Examples and Comparative Examples were produced in the following order.

實施例1: 使聚乙烯醇1.5質量份溶解於純化水20質量份(水相)。 其次,加入水楊酸乙二醇1.25質量份、L-薄荷腦1質量份、聚乙二醇(註冊商標)400(三洋化成工業(股)製造)1質量份,並使其等溶解(油相)。 進而,使聚丙烯酸部分中和物4質量份、羧甲基纖維素鈉4質量份、二羥基鋁胺基乙酸鹽0.25質量份於濃甘油25質量份中均勻地分散(甘油相)。 向攪拌機中依序投入水相、丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(共聚物中之丙烯酸甲酯調配量31.1質量%,乳液中含有微量之聚氧乙烯壬基苯醚(30EO))7質量份、依地酸鈉水合物0.20質量份、及D-山梨糖醇70%水溶液30質量份,並使其等均勻地分散或溶解。於其中依序投入油相、甘油相,均勻地進行混練。進而,加入乳酸1質量份,利用純化水以總質量成為100質量份之方式進行質量修正後,於脫氣條件下,均勻地進行混練,獲得實施例1之黏著劑層形成組合物。 利用狹縫寬度已調整至0.5 mm之延展機將所獲得之黏著劑層形成組合物於襯墊(單面經聚矽氧處理之PET(Polyethylene Terephthalate,聚對苯二甲酸乙二酯)(75 μm))之聚矽氧面上進行延展,對針織物支持體(聚酯製)進行層壓後,於50℃使其熟化1週。熟化後,衝壓成任意之形狀,獲得實施例1之製劑。Example 1: 1.5 parts by mass of polyvinyl alcohol was dissolved in 20 parts by mass of purified water (aqueous phase). Next, add 1.25 parts by mass of ethylene glycol salicylate, 1 part by mass of L-menthol, and 1 part by mass of polyethylene glycol (registered trademark) 400 (manufactured by Sanyo Chemical Industry Co., Ltd.), and dissolve it (oil phase). Furthermore, 4 parts by mass of polyacrylic acid partial neutralized product, 4 parts by mass of sodium carboxymethylcellulose, and 0.25 parts by mass of dihydroxy aluminum aminoacetate were uniformly dispersed in 25 parts by mass of concentrated glycerin (glycerin phase). Aqueous phase, methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (the amount of methyl acrylate in the copolymer is 31.1% by mass, and the emulsion contains a small amount of polyoxyethylene nonylphenyl ether (30EO )) 7 parts by mass, 0.20 parts by mass of sodium edetate hydrate, and 30 parts by mass of a 70% aqueous solution of D-sorbitol, which are uniformly dispersed or dissolved. Put oil phase and glycerin phase in this order, and mix evenly. Furthermore, after adding 1 part by mass of lactic acid and performing mass correction using purified water so that the total mass becomes 100 parts by mass, the mixture was uniformly kneaded under degassing conditions to obtain the adhesive layer forming composition of Example 1. Using a spreader with slit width adjusted to 0.5 mm, the obtained adhesive layer forming composition was placed on the liner (PET (Polyethylene Terephthalate, polyethylene terephthalate) treated on one side with polysiloxane) (75 μm)) The polysilicon surface is stretched, and the knitted fabric support (made of polyester) is laminated and then cured at 50°C for 1 week. After aging, it was punched into an arbitrary shape to obtain the preparation of Example 1.

實施例2: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量31.1質量%)變更為丙烯酸甲酯之調配量為40.8質量%之乳液,除此以外,以與實施例1相同之方式獲得實施例2之製劑。Example 2: It was the same as Example 1 except that the methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate blending amount 31.1% by mass) was changed to an emulsion of methyl acrylate blending amount of 40.8% by mass. The formulation of Example 2 was obtained in a manner.

實施例3: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量31.1質量%)變更為丙烯酸甲酯之調配量為46.7質量%之乳液,除此以外,以與實施例1相同之方式獲得實施例3之製劑。Example 3: It was the same as Example 1 except that the methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate blending amount 31.1% by mass) was changed to an emulsion of methyl acrylate blending amount of 46.7% by mass. The formulation of Example 3 was obtained in a manner.

實施例4: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液變更為甲基丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(共聚物中之甲基丙烯酸甲酯調配量30.0質量%)10質量份(共聚物之固形物成分換算值為4.34質量份),除此以外,以與實施例1相同之方式獲得實施例4之製劑。Example 4: Changed methyl acrylate-2-ethylhexyl acrylate copolymer emulsion to methyl methacrylate-2-ethylhexyl acrylate copolymer emulsion (the amount of methyl methacrylate in the copolymer is 30.0% by mass) 10 parts by mass (The conversion value of the solid content of the copolymer is 4.34 parts by mass), except that the preparation of Example 4 is obtained in the same manner as in Example 1.

實施例5: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液變更為甲基丙烯酸乙酯-丙烯酸2-乙基己酯共聚乳液(共聚物中之甲基丙烯酸乙酯調配量30.0質量%)10質量份(共聚物之固形物成分換算值為4.14質量份),除此以外,以與實施例1相同之方式獲得實施例5之製劑。Example 5: Changed methyl acrylate-2-ethylhexyl acrylate copolymer emulsion to ethyl methacrylate-2-ethylhexyl acrylate copolymer emulsion (the amount of ethyl methacrylate in the copolymer is 30.0% by mass) 10 parts by mass (The conversion value of the solid content of the copolymer is 4.14 parts by mass), except that the preparation of Example 5 is obtained in the same manner as in Example 1.

實施例6: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液變更為甲基丙烯酸正丁酯-丙烯酸2-乙基己酯共聚乳液(共聚物中之甲基丙烯酸正丁酯調配量30.0質量%)10質量份(共聚物之固形物成分換算值為4.34質量份),除此以外,以與實施例1相同之方式獲得實施例6之製劑。Example 6: Changed methyl acrylate-2-ethylhexyl acrylate copolymer emulsion to n-butyl methacrylate-2-ethylhexyl acrylate copolymer emulsion (the amount of n-butyl methacrylate in the copolymer is 30.0% by mass) 10 The formulation of Example 6 was obtained in the same manner as in Example 1 except for parts by mass (the conversion value of the solid content of the copolymer was 4.34 parts by mass).

實施例7: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液變更為丙烯酸甲酯-丙烯酸正丁酯共聚乳液(共聚物中之丙烯酸甲酯調配量30.0質量%)10質量份(共聚物之固形物成分換算值為4.54質量份),除此以外,以與實施例1相同之方式獲得實施例7之製劑。Example 7: Changed methyl acrylate-2-ethylhexyl acrylate copolymer emulsion to methyl acrylate-n-butyl acrylate copolymer emulsion (the amount of methyl acrylate in the copolymer is 30.0% by mass) 10 parts by mass (solid content of the copolymer) The conversion value was 4.54 parts by mass), except that the preparation of Example 7 was obtained in the same manner as Example 1.

實施例8: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量31.1質量%)變更為丙烯酸甲酯之調配量為46.7質量%之乳液,且將其調配量變更為5質量份(共聚物之固形物成分換算值為2.95質量份),除此以外,以與實施例1相同之方式獲得實施例8之製劑。Example 8: The methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate blending amount 31.1% by mass) was changed to an emulsion of methyl acrylate blending amount of 46.7% by mass, and the blending amount was changed to 5 parts by mass ( The conversion value of the solid content of the copolymer was 2.95 parts by mass), except that the preparation of Example 8 was obtained in the same manner as Example 1.

實施例9: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量31.1質量%)變更為丙烯酸甲酯之調配量為46.7質量%之乳液,且將其調配量變更為10質量份(共聚物之固形物成分換算值為5.9質量份),除此以外,以與實施例1相同之方式獲得實施例9之製劑。Example 9: The methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate blending amount 31.1% by mass) was changed to an emulsion of methyl acrylate blending amount of 46.7% by mass, and the blending amount was changed to 10 parts by mass ( The conversion value of the solid content of the copolymer was 5.9 parts by mass), except that the preparation of Example 9 was obtained in the same manner as in Example 1.

實施例10: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量31.1質量%)變更為丙烯酸甲酯之調配量為46.7質量%之乳液,且將其調配量變更為12質量份(共聚物之固形物成分換算值為7.08質量份),除此以外,以與實施例1相同之方式獲得實施例10之製劑。Example 10: The methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate blending amount 31.1% by mass) was changed to an emulsion of methyl acrylate blending amount of 46.7% by mass, and the blending amount was changed to 12 parts by mass ( The conversion value of the solid content of the copolymer was 7.08 parts by mass), except that the preparation of Example 10 was obtained in the same manner as in Example 1.

實施例11: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量31.1質量%)變更為丙烯酸甲酯之調配量為46.7質量%之乳液,且將其調配量變更為15質量份(共聚物之固形物成分換算值為8.85質量份),除此以外,以與實施例1相同之方式獲得實施例11之製劑。Example 11: The methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate blending amount 31.1% by mass) was changed to an emulsion of methyl acrylate blending amount of 46.7% by mass, and the blending amount was changed to 15 parts by mass ( The conversion value of the solid content of the copolymer was 8.85 parts by mass), except that the preparation of Example 11 was obtained in the same manner as in Example 1.

實施例12: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量31.1質量%)變更為丙烯酸甲酯之調配量為46.7質量%之乳液,且將其調配量變更為20質量份(共聚物之固形物成分換算值為11.8質量份),除此以外,以與實施例1相同之方式獲得實施例12之製劑。Example 12: The methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate blending amount 31.1% by mass) was changed to an emulsion of methyl acrylate blending amount of 46.7% by mass, and the blending amount was changed to 20 parts by mass ( The conversion value of the solid content of the copolymer was 11.8 parts by mass), except that the preparation of Example 12 was obtained in the same manner as in Example 1.

比較例1: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量31.1質量%)變更為丙烯酸甲酯之調配量為14.7質量%之乳液,除此以外,以與實施例1相同之方式獲得比較例1之製劑。Comparative example 1: It was the same as Example 1 except that the methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate blending amount 31.1% by mass) was changed to an emulsion of methyl acrylate blending amount of 14.7% by mass. To obtain the preparation of Comparative Example 1.

比較例2: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量31.1質量%)變更為丙烯酸甲酯之調配量為27.0質量%之乳液,除此以外,以與實施例1相同之方式獲得比較例2之製劑。Comparative example 2: It was the same as Example 1 except that the methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate blending amount 31.1% by mass) was changed to an emulsion of methyl acrylate blending amount of 27.0% by mass. To obtain the preparation of Comparative Example 2.

比較例3: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量14.7質量%)之調配量變更為10質量份(10質量%),除此以外,以與比較例1相同之方式獲得比較例3之製劑。Comparative Example 3: The formulation amount of the methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate formulation amount 14.7% by mass) was changed to 10 parts by mass (10% by mass), except that it was the same as in Comparative Example 1. The preparation of Comparative Example 3 was obtained.

比較例4: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量14.7質量%)之調配量變更為15質量份(15質量%),除此以外,以與比較例1相同之方式獲得比較例4之製劑。Comparative Example 4: The formulation amount of the methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate formulation amount 14.7% by mass) was changed to 15 parts by mass (15% by mass), except that it was the same as in Comparative Example 1. The preparation of Comparative Example 4 was obtained.

比較例5: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量14.7質量%)之調配量變更為20質量份(20質量%),除此以外,以與比較例1相同之方式獲得比較例5之製劑。Comparative Example 5: The formulation amount of the methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate formulation amount 14.7% by mass) was changed to 20 parts by mass (20% by mass), except that it was the same as in Comparative Example 1. The preparation of Comparative Example 5 was obtained.

比較例6: 將丙烯酸甲酯-丙烯酸2-乙基己酯共聚乳液(丙烯酸甲酯調配量14.7質量%)之調配量變更為25質量份(25質量%),除此以外,以與比較例1相同之方式獲得比較例6之製劑。Comparative Example 6: The formulation amount of the methyl acrylate-2-ethylhexyl acrylate copolymer emulsion (methyl acrylate formulation amount 14.7% by mass) was changed to 25 parts by mass (25% by mass), except that it was the same as Comparative Example 1. The preparation of Comparative Example 6 was obtained.

再者,關於上述實施例1至實施例3、比較例1及比較例2中之共聚乳液之調配量,共聚物之固形物成分換算值以構成黏著劑層之所有成分之質量為基準為4.13質量%、實施例4及實施例6以同樣基準為4.34質量%、實施例5及實施例7以同樣基準為4.14質量%、實施例8以同樣基準為2.95質量%、實施例9以同樣基準為5.90質量%、實施例10以同樣基準為7.08質量%、實施例11以同樣基準為8.85質量%、實施例12以同樣基準為11.80質量%、比較例3以同樣基準為5.90質量%、比較例4以同樣基準為8.85質量%、比較例5以同樣基準為11.80質量%、比較例6以同樣基準為14.75質量%。In addition, regarding the blending amount of the copolymer emulsion in the above Examples 1 to 3, Comparative Example 1 and Comparative Example 2, the conversion value of the solid content of the copolymer is 4.13 based on the mass of all components constituting the adhesive layer Mass%, Example 4 and Example 6 are 4.34 mass% on the same basis, Example 5 and Example 7 are 4.14 mass% on the same basis, Example 8 is 2.95 mass% on the same basis, and Example 9 is the same basis Was 5.90 mass%, Example 10 was 7.08 mass% on the same basis, Example 11 was 8.85 mass% on the same basis, Example 12 was 11.80 mass% on the same basis, and Comparative Example 3 was 5.90 mass% on the same basis. Example 4 is 8.85 mass% on the same basis, Comparative Example 5 is 11.80 mass% on the same basis, and Comparative Example 6 is 14.75 mass% on the same basis.

參考例1、參考例2: 使用市售之貼劑(FEITAS(註冊商標)5.0,久光製藥(股),批號:SC08T)作為參考例1之製劑,使用市售之敷劑(Vantelin kowa新迷你墊,興和(股),批號:NA640)作為參考例2之製劑,而供至下述之各種試驗。Reference Example 1, Reference Example 2: Using a commercially available patch (FEITAS (registered trademark) 5.0, Jiuguang Pharmaceutical Co., Ltd., batch number: SC08T) as the formulation of Reference Example 1, a commercially available patch (Vantelin kowa new mini pad, Xinghe Co., Ltd., batch number) : NA640) As the preparation of Reference Example 2, it was used for various tests described below.

試驗例1(黏著力試驗) 關於實施例1至實施例12、比較例1至比較例6、以及參考例1及參考例2之各製劑,針對初始(以後稱為“含水時”,實施例及比較例之製劑係剛製造後,參考例之製劑係剛打開製品之包裝後)、及於50℃下乾燥一晚時(以後稱為“乾燥時”,所有製劑均於剝離了襯墊之狀態(使黏著劑層露出之狀態)下於50℃下保持一晩)之傾斜式滾球黏性黏著力,依據日本藥典一般試驗法 6.12黏著力試驗法 3.2傾斜式滾球黏性試驗法實施測定。 將所獲得之結果示於表2及表3。Test Example 1 (Adhesion Test) Regarding the preparations of Examples 1 to 12, Comparative Examples 1 to 6, and Reference Examples 1 and 2, for the initial (hereinafter referred to as "aqueous"), the preparations of Examples and Comparative Examples were just manufactured After that, the formulation of the reference example is just after opening the package of the product), and when it is dried at 50°C overnight (hereinafter referred to as "dried"), all formulations are in a state where the liner is peeled off (the adhesive layer is exposed State) maintained at 50°C for one night) of the tilting ball adhesive force, measured according to the Japanese Pharmacopoeia General Test Method 6.12 Adhesion Test Method 3.2 Inclined Ball Adhesive Test Method. The obtained results are shown in Table 2 and Table 3.

試驗例2(膏體間剝離性及再附著性試驗) 對實施例1至實施例12、比較例1至比較例6、以及參考例1及參考例2之各製劑進行膏體間剝離性及再附著性之評價。 將所獲得之結果合併示於表2及表3。 1)膏體間剝離性 將剪裁為5 cm×5 cm之大小之各製劑之襯墊進行剝離,將各製劑對折,使黏著劑層彼此牢牢地貼合,並靜止30秒鐘。其後,將貼合部分剝離,依據下述基準進行評價(N=3)。 ○:容易地剝離 △:雖剝離但發生變形 ×:未剝離 2)再附著性 將各製劑(10 cm×7 cm)之襯墊剝離,貼附於人上臂內部。經過30秒鐘後,將之剝離,再次貼附於前臂部之其他部分,依據下述基準進行評價(N=3)。 ○:有再附著性 △:再附著性較弱 ×:無再附著性Test Example 2 (Removability and re-adhesion test between pastes) The formulations of Examples 1 to 12, Comparative Examples 1 to 6, and Reference Examples 1 and 2 were evaluated for releasability and reattachability between pastes. The obtained results are combined and shown in Table 2 and Table 3. 1) Peelability between pastes Peel off the liner of each preparation cut to a size of 5 cm×5 cm, fold the preparations in half so that the adhesive layers are firmly attached to each other, and stand still for 30 seconds. Thereafter, the bonded portion was peeled off and evaluated according to the following criteria (N=3). ○: easily peeled off △: Deformed although peeling off ×: Not peeled 2) Reattachment The liner of each preparation (10 cm×7 cm) was peeled off and attached to the inside of the person's upper arm. After 30 seconds, it was peeled off and attached to the other parts of the forearm again, and evaluated according to the following criteria (N=3). ○: Reattachability △: Reattachment is weak ×: No re-adhesion

[表2]

Figure 108122813-A0304-0002
[Table 2]
Figure 108122813-A0304-0002

[表3]

Figure 108122813-A0304-0003
[table 3]
Figure 108122813-A0304-0003

<試驗結果> 如表2所示,關於實施例1至實施例9之製劑,其等使用構成丙烯酸烷基酯系共聚物之單體中,該單體之均聚物之Tg為270 K以上之單體A之調配量、即丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂中之丙烯酸甲酯之調配量、甲基丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂中之甲基丙烯酸甲酯之調配量、甲基丙烯酸乙酯-丙烯酸2-乙基己酯共聚樹脂中之甲基丙烯酸乙酯之調配量、甲基丙烯酸正丁酯-丙烯酸2-乙基己酯共聚樹脂中之甲基丙烯酸正丁酯之調配量、丙烯酸甲酯-丙烯酸正丁酯共聚樹脂中之丙烯酸甲酯之調配量為30質量%以上之樹脂乳液,雖結果為剛製造後(含水時)之滾球黏性黏著力稍稍低於市售之貼劑(參考例1)與市售之敷劑(參考例2)(參照表3),但乾燥時(50℃乾燥一晚)之滾球黏性黏著力表現出與市售之貼劑幾乎同等之黏著力。又,如實施例3及實施例8至實施例12之結果所示,伴隨丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂(丙烯酸甲酯調配量:46.7質量%)之調配量之增加,於剛製造後(含水時)及乾燥時之任意時點黏著力均增加,尤其是實施例10至實施例12中,即便於含水時亦表現出與上述參考例1及參考例2所示之市售品相比同等以上之黏著力。又,於任一實施例中,即便使黏著劑層彼此附著,亦可容易地剝離,且亦發現再附著性,即便增加丙烯酸烷基酯系共聚物之調配量,該等性能亦得到保持。<Test results> As shown in Table 2, regarding the preparations of Examples 1 to 9, among the monomers constituting the alkyl acrylate copolymer, the homopolymer of the monomer has a Tg of 270 K or more. The blending amount, that is, the blending amount of methyl acrylate in the methyl acrylate-2-ethylhexyl acrylate copolymer resin, the methyl methacrylate in the methyl methacrylate-2-ethylhexyl acrylate copolymer resin Blending amount, blending amount of ethyl methacrylate in ethyl methacrylate-2-ethylhexyl acrylate copolymer resin, methacrylic acid in n-butyl methacrylate-2-ethylhexyl acrylate copolymer resin The compounding amount of n-butyl ester and the compounding amount of methyl acrylate in the methyl acrylate-n-butyl acrylate copolymer resin is 30% by mass or more, although the result is the ball adhesiveness immediately after manufacturing (when water is contained) The force is slightly lower than the commercially available patch (Reference Example 1) and the commercially available dressing (Reference Example 2) (refer to Table 3), but the dry ball (drying at 50 ℃ overnight) shows the adhesive strength of the rolling ball It has almost the same adhesive strength as the commercially available patch. In addition, as shown in the results of Example 3 and Example 8 to Example 12, with the increase in the blending amount of the methyl acrylate-2-ethylhexyl acrylate copolymer resin (methyl acrylate blending amount: 46.7% by mass), The adhesive strength increases at any point immediately after manufacturing (when water is included) and when it is dried, especially in Examples 10 to 12, even when it is water, it exhibits the same market as shown in Reference Examples 1 and 2 above. Compared with the same level of adhesion. Moreover, in any of the embodiments, even if the adhesive layers are attached to each other, they can be easily peeled off, and re-adhesion is also found. Even if the amount of the alkyl acrylate copolymer is increased, these properties are maintained.

另一方面,成為如下結果,即上述單體A之調配量、即丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂之丙烯酸甲酯之調配量未達30質量%之製劑(比較例1及2)之乾燥時之滾球黏性黏著力低於實施例1~12。再者,如上所述,若丙烯酸甲酯之調配量超過50質量%,則乳液發生凝集、沈澱而變得難以再分散,調配量之上限為50質量%。 又,關於比較例1中所採用之丙烯酸甲酯之調配量為14.7質量%之丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂,成為如下結果,即,將該共聚樹脂之調配量於7質量%至25質量%(以固形物成分計為4.13質量%~14.75質量%)之範圍內增加之製劑(比較例1、比較例3至比較例6)於含水時以及乾燥時均滾球黏性黏著力低於實施例1至實施例3之製劑。 再者,比較例1至比較例4之製劑被評價為膏體間剝離性、再附著性與實施例之製劑相同,但比較例5及比較例6之製劑被評價為膏體間剝離性、再附著性均不及實施例之製劑,發現了因丙烯酸烷基酯系共聚物之調配量增加而該等性能反而變差之傾向。On the other hand, as a result, the preparation amount of the monomer A, that is, the preparation amount of the methyl acrylate of the methyl acrylate-2-ethylhexyl acrylate copolymer resin was less than 30% by mass (Comparative Examples 1 and 2) The adhesive strength of the roller ball during drying is lower than that of Examples 1-12. In addition, as described above, if the blending amount of methyl acrylate exceeds 50% by mass, the emulsion will agglomerate and precipitate, making it difficult to redisperse, and the upper limit of the blending amount is 50% by mass. In addition, regarding the methyl acrylate-2-ethylhexyl acrylate copolymer resin with the compounding amount of methyl acrylate used in Comparative Example 1 being 14.7% by mass, the following result was obtained, that is, the compounding amount of the copolymer resin was 7 Formulations (Comparative Example 1, Comparative Example 3 to Comparative Example 6) that increase in the range of mass% to 25% by mass (4.13% by mass to 14.75% by mass in terms of solid content) are sticky when they are hydrated and when dried The adhesive strength is lower than the preparations of Examples 1 to 3. In addition, the preparations of Comparative Examples 1 to 4 were evaluated as having peelability between pastes, and the re-adhesion was the same as the preparations of Examples, but the preparations of Comparative Examples 5 and 6 were evaluated as having peelability between pastes, The reattachability was not as good as the formulations of the examples, and it was found that these properties tended to deteriorate due to the increased amount of alkyl acrylate copolymers.

並且,作為市售之製劑之參考例1之製劑被評價為使黏著劑層彼此附著時未剝落,且不具有再貼附性。 又,於參考例2之製劑時,成為如下結果,即,使黏著劑層彼此附著後,雖剝離但發生變形,又,雖再貼附但附著性變弱。In addition, the preparation of Reference Example 1, which is a commercially available preparation, was evaluated so that the adhesive layers did not peel off when they were attached to each other, and did not have reattachability. In addition, in the preparation of Reference Example 2, the result was that after the adhesive layers were adhered to each other, they were peeled but deformed, and after being attached again, the adhesion became weak.

根據以上之結果,確認到藉由採用構成丙烯酸烷基酯系共聚物之單體中,該單體之均聚物之Tg為270 K以上之單體A(丙烯酸甲酯等)之調配量為30~50質量%之丙烯酸烷基酯系共聚物(丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂等),而成為不僅含水時黏著力優異,就連乾燥時之黏著力亦優異之製劑,又,確認到成為膏體間剝離性較容易且具有再附著性之製劑。Based on the above results, it was confirmed that by using the monomer constituting the alkyl acrylate copolymer, the amount of the monomer A (methyl acrylate, etc.) whose homopolymer has a Tg of 270 K or more is 30-50% by mass of alkyl acrylate copolymer (methyl acrylate-2-ethylhexyl acrylate copolymer resin, etc.), which is not only excellent in adhesion when water is contained, but also excellent in adhesion even when dried Also, it was confirmed that it was easy to peel between the pastes and had re-adhesion.

試驗例3(皮膚一次刺激性指數試驗) 基於崔氏試驗法之皮膚一次刺激性指數(P.I.I.)試驗係藉由以下之方法進行。再者,崔氏試驗法之詳情係示於Draize J.H., Woodard, G. and Calvery, H.0.(1944):Methods for the study of irritation and Toxicity of substances applied topically to the skin and mocous membranes, J. Pharmacol Exp. Ther., 82:377-390)中。Test Example 3 (Skin Irritation Index Test) The skin primary irritation index (P.I.I.) test based on the Choi test method is performed by the following method. Furthermore, the details of the Choi test method are shown in Draize JH, Woodard, G. and Calvery, H.0. (1944): Methods for the study of irritation and Toxicity of substances applied topically to the skin and mocous membranes, J . Pharmacol Exp. Ther., 82:377-390).

將實施例3、比較例1之製劑沖裁為15 mm

Figure 02_image001
,將剝離襯墊剝離後,貼附於經剪毛及剃毛處理之白色兔子(17週齡,雄,JW)(N=3)之背部,以覆蓋所貼附之製劑整體之方式自該製劑之上方貼附具有透濕性之CATHEREEP(透明黏著膜,米其邦(股))。 貼附24小時後,將CATHEREEP及製劑剝離,利用純化水擦拭該製劑之貼附部位,觀察剝離30分鐘後及經過24小時之時之貼附部位之皮膚狀態,依據表4所示之崔氏試驗之基準而實施刺激反應之評分。 又,基於製劑剝離30分鐘後及24小時後之評分值,根據30分鐘後或24小時後之評分平均值、及各個體之皮膚一次刺激性指數(P.I.I),獲得作為個體平均值之平均皮膚一次刺激性指數(平均P.I.I.)。 再者,使用DNBC(2,4-dinitrochloro-benzene,二硝基氯苯)作為陽性對照,使用市售之敷劑(Nobinobi Salonsip(註冊商標)FH溫感,久光製藥(股))作為參考例3之製劑,使用市售之敷劑(Halix(註冊商標)55EX溫感,LION(股))作為參考例4之製劑,以相同方式實施皮膚一次刺激性指數試驗,獲得30分鐘後或24小時後之評分平均值、各個體之皮膚一次刺激性指數(P.I.I)及皮膚一次刺激性指數(平均P.I.I.)。 將所獲得之結果示於表5。Punch the preparations of Example 3 and Comparative Example 1 to 15 mm
Figure 02_image001
After peeling off the release liner, attach it to the back of a white rabbit (17 weeks old, male, JW) (N=3) treated with shearing and shaving, and cover the whole of the attached preparation from the preparation Attach the CATHEREEP (transparent adhesive film, Miqibang (share)) with moisture permeability on the top. After 24 hours of application, remove the CATHEREEP and the preparation, wipe the application site of the preparation with purified water, and observe the skin condition of the application site after 30 minutes of peeling and 24 hours, according to Choi's shown in Table 4 The stimulus response was scored based on the test. Also, based on the score values after 30 minutes and 24 hours after the preparation was peeled off, the average skin as an individual average value was obtained based on the average score after 30 minutes or 24 hours and the skin primary irritation index (PII) of each individual One-time irritation index (average PII). In addition, DNBC (2,4-dinitrochloro-benzene) was used as a positive control, and a commercially available compress (Nobinobi Salonsip (registered trademark) FH Wengan, Jiuguang Pharmaceutical Co., Ltd.) was used as a reference example. For the preparation of 3, using a commercially available compress (Halix (registered trademark) 55EX Wengan, LION (share)) as the preparation of Reference Example 4, a skin irritation index test was carried out in the same manner, after 30 minutes or 24 hours The average of the subsequent scores, the primary skin irritation index (PII) and the primary skin irritation index (average PII) of each body. Table 5 shows the obtained results.

[表4] 表4 皮膚一次刺激性試驗之評價基準(崔氏試驗之基準)

Figure 108122813-A0304-0004
[Table 4] Table 4 Evaluation criteria for one skin irritation test (Cui's test criteria)
Figure 108122813-A0304-0004

[表5] 表5 兔子之皮膚一次刺激性試驗結果

Figure 108122813-A0304-0005
*1 平均=各個體中之紅斑及浮腫之評價之合計分數之平均值(3隻) *2 一次刺激性指數(P.I.I.)=製劑剝離後30分鐘及24小時之各個評分之合計/2 *3 平均一次刺激性指數(平均P.I.I.)=各個體之P.I.I.之合計/3(隻) *4 SE:標準誤差[Table 5] Table 5 Results of a skin irritation test for rabbits
Figure 108122813-A0304-0005
*1 Average = the average value of the total score of the evaluation of erythema and edema in each body (3 animals) *2 Primary Irritation Index (PII) = the total score of each score 30 minutes and 24 hours after the peeling of the preparation/2 *3 Average primary irritation index (average PII) = total PII of each individual/3 (only) *4 SE: standard error

如表5所示,結果為,實施例3、比較例1、參考例3及參考例4之製劑中之平均一次刺激性指數(平均P.I.I.)成為0.7~1.0,係輕度之刺激。 另一方面,陽性對照中之平均一次刺激性指數(平均P.I.I.)成為2.8,係中度之刺激。As shown in Table 5, as a result, the average primary irritation index (average P.I.I.) in the preparations of Example 3, Comparative Example 1, Reference Example 3, and Reference Example 4 became 0.7 to 1.0, which was mild stimulation. On the other hand, the average primary irritation index (average P.I.I.) in the positive control became 2.8, which was a moderate irritation.

根據以上之實施例結果,確認到根據本發明,藉由將構成丙烯酸烷基酯系共聚物之單體中,該單體之均聚物之Tg為270 K以上之單體A(丙烯酸甲酯等)含量為30~50質量%之丙烯酸烷基酯系共聚物(丙烯酸甲酯-丙烯酸2-乙基己酯共聚樹脂等)調配至含水系貼附劑之黏著劑層,可提供一種維持含水時及乾燥時之較高黏著性,並且皮膚刺激性較低之貼附劑。Based on the results of the above examples, it was confirmed that according to the present invention, among the monomers constituting the alkyl acrylate copolymer, the homopolymer of the monomer has a Tg of 270 K or more of monomer A (methyl acrylate Etc.) The alkyl acrylate copolymer (methyl acrylate-2-ethylhexyl acrylate copolymer resin, etc.) with a content of 30 to 50% by mass is formulated into the adhesive layer of the water-based adhesive to provide a means to maintain water content. Adhesive with high adhesiveness when dry and dry, and low skin irritation.

Claims (4)

一種含水系貼附劑,其係含有支持體、設置於該支持體上之黏著劑層、及剝離襯墊者,且 上述黏著劑層係含有下述1)~6)成分作為必須成分而成: 1)丙烯酸系親水性黏著劑; 2)丙烯酸烷基酯系共聚物,其係包含單體A與單體B之單體混合物之共聚物, 上述單體A於使該單體A均聚時會成為玻璃轉移溫度(Tg)為270 K以上之聚合物者, 上述單體B於使該單體B均聚時會成為玻璃轉移溫度(Tg)為220 K以下之聚合物者,且 相對於上述單體混合物之總質量,上述單體A之比率為30質量%以上50質量%以下之比率; 3)有機溶劑; 4)交聯劑; 5)有機酸;及 6)水。An aqueous adhesive, which contains a support, an adhesive layer provided on the support, and a release liner, and The above adhesive layer system contains the following components 1) to 6) as essential components: 1) Acrylic hydrophilic adhesive; 2) Alkyl acrylate copolymer, which is a copolymer containing a monomer mixture of monomer A and monomer B, When the above monomer A homopolymerizes the monomer A, it will become a polymer having a glass transition temperature (Tg) of 270 K or more, The above monomer B becomes a polymer having a glass transition temperature (Tg) of 220 K or less when the monomer B is homopolymerized, and Relative to the total mass of the monomer mixture, the ratio of the monomer A is 30% by mass or more and 50% by mass or less; 3) Organic solvents; 4) Crosslinking agent; 5) Organic acids; and 6) Water. 如請求項1之含水系貼附劑,其中 上述單體A係選自由丙烯酸甲酯、甲基丙烯酸甲酯、甲基丙烯酸乙酯、甲基丙烯酸正丁酯、甲基丙烯酸異丁酯、甲基丙烯酸第三丁酯、乙酸乙烯酯、丙烯腈、丙烯醯胺及苯乙烯所組成之群中之至少一種單體, 上述單體B係選自由丙烯酸丁酯、丙烯酸2-乙基己酯、丙烯酸辛酯及丙烯酸異壬酯所組成之群中之至少一種單體。If the water-based patch of claim 1, wherein The above monomer A is selected from the group consisting of methyl acrylate, methyl methacrylate, ethyl methacrylate, n-butyl methacrylate, isobutyl methacrylate, third butyl methacrylate, vinyl acetate, propylene At least one monomer in the group consisting of nitrile, acrylamide and styrene, The monomer B is at least one monomer selected from the group consisting of butyl acrylate, 2-ethylhexyl acrylate, octyl acrylate, and isononyl acrylate. 如請求項2之含水系貼附劑,其中 上述單體A係選自由丙烯酸甲酯、甲基丙烯酸甲酯、甲基丙烯酸乙酯及甲基丙烯酸正丁酯所組成之群中之至少一種單體, 上述單體B係選自由丙烯酸2-乙基己酯及丙烯酸丁酯所組成之群中之至少一種單體。If the water-based patch of claim 2, wherein The above monomer A is at least one monomer selected from the group consisting of methyl acrylate, methyl methacrylate, ethyl methacrylate and n-butyl methacrylate, The above monomer B is at least one monomer selected from the group consisting of 2-ethylhexyl acrylate and butyl acrylate. 如請求項1至3中任一項之含水系貼附劑,其進而含有有效成分。The aqueous patch according to any one of claims 1 to 3, which further contains an active ingredient.
TW108122813A 2018-09-26 2019-06-28 Hydrated adhesive skin patch TW202011993A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018180413 2018-09-26
JP2018-180413 2018-09-26

Publications (1)

Publication Number Publication Date
TW202011993A true TW202011993A (en) 2020-04-01

Family

ID=69952547

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108122813A TW202011993A (en) 2018-09-26 2019-06-28 Hydrated adhesive skin patch

Country Status (5)

Country Link
JP (1) JP7257410B2 (en)
KR (1) KR20210065931A (en)
CN (1) CN112689505A (en)
TW (1) TW202011993A (en)
WO (1) WO2020066188A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI755236B (en) * 2020-04-08 2022-02-11 台達電子工業股份有限公司 Wavelength converting device

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022064608A1 (en) * 2020-09-24 2022-03-31
WO2022064607A1 (en) * 2020-09-24 2022-03-31 ニチバン株式会社 Hydrous patch for drug

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4751808B1 (en) * 1969-07-12 1972-12-26
US3807470A (en) 1972-10-16 1974-04-30 Ingersoll Rand Canada Drum-type debarking apparatus
JPS5921779B2 (en) 1980-08-28 1984-05-22 住友ゴム工業株式会社 Mold for multiple extrusion of thermoplastic materials
AU547201B2 (en) * 1981-07-07 1985-10-10 Marley Tile Ag Mortars or concretes with acrylate polymer additives
JPH062150B2 (en) * 1983-09-12 1994-01-12 リ−ドケミカル株式会社 Base for patches
GB8813557D0 (en) * 1988-06-08 1988-07-13 James River Graphics Ltd Coating composition & coated paper
JP2932574B2 (en) * 1989-06-30 1999-08-09 ライオン株式会社 Additive for cement mortar and / or concrete
JPH09208462A (en) 1996-02-07 1997-08-12 Tsumura & Co Autoadhesive cataplasm
JP3456828B2 (en) * 1996-04-12 2003-10-14 日本カーバイド工業株式会社 Acrylic water-based pressure-sensitive adhesive composition
JP2002104957A (en) 2000-09-29 2002-04-10 Ooshin Seiyaku Kk Patch for external use
EP1559426B1 (en) * 2002-11-05 2011-02-09 Lead Chemical Co. Ltd. Percutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one
JP4527949B2 (en) * 2003-06-24 2010-08-18 ニプロパッチ株式会社 Adhesive tape
CA2552679C (en) * 2004-01-20 2012-12-11 Saitama Daiichi Pharmaceutical Co., Ltd. Tulobuterol adhesive patch
JP4665446B2 (en) * 2004-07-02 2011-04-06 東洋インキ製造株式会社 Aqueous pressure-sensitive adhesive composition and method for producing the same
WO2006090782A1 (en) * 2005-02-23 2006-08-31 Saitama Daiichi Pharmaceutical Co., Ltd. Composition for hydrous adhesive patch for external use and adhesive patch comprising the composition
JP2011182847A (en) * 2010-03-05 2011-09-22 Three M Innovative Properties Co Medical adhesive composition
WO2012102242A1 (en) * 2011-01-24 2012-08-02 ニプロパッチ株式会社 Hydrous adhesive patch
CN107286856A (en) * 2012-10-19 2017-10-24 琳得科株式会社 Adhesive composition and bonding sheet
BR112016003675B1 (en) * 2013-08-23 2022-11-22 Hisamitsu Pharmaceutical Co., Inc POULTICE AND METHOD FOR PRODUCING THE SAME
ES2721441T3 (en) * 2013-10-25 2019-07-31 Kuraray Co Hot melt adhesive composition
JP6469136B2 (en) 2014-12-22 2019-02-13 久光製薬株式会社 Poultice
JP6183821B2 (en) * 2015-01-16 2017-08-23 サイデン化学株式会社 Emulsion-type adhesive composition
TWI703196B (en) * 2015-06-17 2020-09-01 日商東亞營養股份有限公司 Bisoprolol-containing patch preparation
JP6304457B2 (en) * 2015-08-27 2018-04-04 東洋インキScホールディングス株式会社 Patch

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI755236B (en) * 2020-04-08 2022-02-11 台達電子工業股份有限公司 Wavelength converting device

Also Published As

Publication number Publication date
KR20210065931A (en) 2021-06-04
JPWO2020066188A1 (en) 2021-08-30
WO2020066188A1 (en) 2020-04-02
CN112689505A (en) 2021-04-20
JP7257410B2 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
JP5650684B2 (en) Water-containing external patch composition and patch using this composition
JP5130203B2 (en) Non-aqueous adhesive composition, patch and method for producing the patch
CA2714143C (en) Water resistant patch preparation
TW202011993A (en) Hydrated adhesive skin patch
CA2548864C (en) Percutaneous absorption-type pharmaceutical preparation
AU2008229842B2 (en) Patch preparation
JP6100948B2 (en) Patch preparation
JP7219177B2 (en) Non-aqueous patches
US20130165876A1 (en) Patch preparation
WO2022064607A1 (en) Hydrous patch for drug
JP2024048993A (en) Patches
JP2022142438A (en) Water-containing patch with moisture sensor function
TW202202147A (en) Transdermal patch
TW202135830A (en) Patch
WO2022064608A1 (en) Hydrous adhesive patch for non-medical product
JP2020164471A (en) Patch
JP2022131753A (en) Non-aqueous patch
WO2021131032A1 (en) Adhesive patch
JPH1149669A (en) Antiviral agent-containing tape preparation